1
|
Chen L, Shang Y, Li Y, Zheng X. Fully endoscopic keyhole approach for intracranial aneurysm clipping: clinical outcomes and technical note. Eur J Med Res 2025; 30:333. [PMID: 40287737 PMCID: PMC12032781 DOI: 10.1186/s40001-025-02594-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2024] [Accepted: 04/14/2025] [Indexed: 04/29/2025] Open
Abstract
BACKGROUND Surgical clipping is often utilized to treat intracranial aneurysms. The application of the endoscopy and keyhole approach in neurosurgery is increasing gradually in intracranial aneurysm occlusion. The aim of this study is to evaluate the role of fully endoscopic keyhole approach in clipping of intracranial aneurysms. METHODS We retrospectively analyzed four cases of intracranial aneurysms, including three cases of middle cerebral artery bifurcation aneurysms (M1) and one case of anterior communicating aneurysms (ACoA). Among them, the anterior communicating aneurysm underwent fully endoscopic clipping via supraorbital keyhole approach and the middle cerebral aneurysms underwent fully endoscopic clipping via mini-pterional keyhole approach. The clipped aneurysms were evaluated by Digital Subtraction Angiography (DSA). RESULTS All patients had satisfactory cerebral aneurysm clipping via the endoscopic keyhole approach. There was no cerebral hemorrhage, cerebral infarction, cerebral vasospasm. One case of intracranial infection was cured by active anti-infection. No recurrence of aneurysms after 6 months of follow-up. CONCLUSION With the advantages of the endoscopy and keyhole approach, the excellent visual field of the endoscope can reduce the influence of intracranial aneurysmal neck residual and perforating vessel. However, endoscopic clipping of intracranial aneurysms in narrow corridors requires a learning curve.
Collapse
Affiliation(s)
- Lulu Chen
- Department of Neurosurgery, The First Affiliated Hospital of Bengbu Medical University, No.287 Changhuai Road, Bengbu, 233000, Anhui, China.
| | - Yuchun Shang
- Department of Neurosurgery, The First Affiliated Hospital of Bengbu Medical University, No.287 Changhuai Road, Bengbu, 233000, Anhui, China
| | - Yu Li
- Department of Neurosurgery, The First Affiliated Hospital of Bengbu Medical University, No.287 Changhuai Road, Bengbu, 233000, Anhui, China
| | - Xialin Zheng
- Department of Neurosurgery, The First Affiliated Hospital of Bengbu Medical University, No.287 Changhuai Road, Bengbu, 233000, Anhui, China
| |
Collapse
|
2
|
Fujiwara K, Shibao S, Sasao R, Nishimoto M. Endoscopic-assisted contralateral interhemispheric transfalcine keyhole approach for falcine meningioma: How I do it. Acta Neurochir (Wien) 2025; 167:88. [PMID: 40126699 PMCID: PMC11933132 DOI: 10.1007/s00701-025-06497-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2024] [Accepted: 03/16/2025] [Indexed: 03/26/2025]
Abstract
BACKGROUND Although the ipsilateral craniotomy approach has been used for the removal of falcine meningioma (FM), we report a case of FM that was minimally invasively removed using a contralateral interhemispheric approach assisted with endoscopy. METHODS We used a contralateral approach with a small craniotomy of the FM. The tumor was detached from the surrounding tissue during internal decompression. It was dissected and coagulated endoscopically in a blind spot under a microscope, and a Simpson Grade I resection was achieved. CONCLUSION A small craniotomy with a contralateral interhemispheric approach assisted by endoscopy allowed minimally invasive tumor removal without complications.
Collapse
Affiliation(s)
- Kouko Fujiwara
- Department of Neurosurgery, Ashikaga Red Cross Hospital, Tochigi, Japan
| | - Shunsuke Shibao
- Department of Neurosurgery, Ashikaga Red Cross Hospital, Tochigi, Japan.
- Department of Neurosurgery, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Shimotsugagun, Tochigi, 321-0293, Japan.
| | - Ryota Sasao
- Department of Neurosurgery, Ashikaga Red Cross Hospital, Tochigi, Japan
| | - Masaaki Nishimoto
- Department of Neurosurgery, Ashikaga Red Cross Hospital, Tochigi, Japan
| |
Collapse
|
3
|
Cuny T, Reynaud R, Raverot G, Coutant R, Chanson P, Kariyawasam D, Poitou C, Thomas-Teinturier C, Baussart B, Samara-Boustani D, Feuvret L, Villanueva C, Villa C, Bouillet B, Tauber M, Espiard S, Castets S, Beckers A, Amsellem J, Vantyghem MC, Delemer B, Chevalier N, Brue T, André N, Kerlan V, Graillon T, Raingeard I, Alapetite C, Raverot V, Salenave S, Boulin A, Appay R, Dalmas F, Fodil S, Coppin L, Buffet C, Thuillier P, Castinetti F, Vogin G, Cazabat L, Kuhn E, Haissaguerre M, Reznik Y, Goichot B, Bachelot A, Kamenicky P, Decoudier B, Planchon C, Micoulaud-Franchi JA, Romanet P, Jacobi D, Faucher P, Carette C, Bihan H, Drui D, Rossignol S, Gonin L, Sokol E, Wiard L, Courtillot C, Nicolino M, Grunenwald S, Chabre O, Christin-Maître S, Desailloud R, Maiter D, Guignat L, Brac de la Perrière A, Salva P, Scavarda D, Bonneville F, Caron P, Vasiljevic A, Leclercq D, Cortet C, Gaillard S, Albarel F, Clément K, Jouanneau E, Dufour H, Barat P, Gatta-Cherifi B. Diagnosis and management of children and adult craniopharyngiomas: A French Endocrine Society/French Society for Paediatric Endocrinology & Diabetes Consensus Statement. ANNALES D'ENDOCRINOLOGIE 2025; 86:101631. [PMID: 39002896 DOI: 10.1016/j.ando.2024.07.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/16/2024] [Accepted: 07/07/2024] [Indexed: 07/15/2024]
Affiliation(s)
- Thomas Cuny
- AP-HM, Department of Endocrinology, Hôpital de la Conception, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Aix-Marseille Université, Inserm, U1251, Marseille Medical Genetics (MMG), Institut Marseille Maladies Rares (MarMaRa), 13005 Marseille, France.
| | - Rachel Reynaud
- AP-HM, Multidisciplinary Pediatrics Department, Hôpital de la Timone, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Aix-Marseille Université, Inserm, U1251, Marseille Medical Genetics (MMG), Institut Marseille Maladies Rares (MarMaRa), 13005 Marseille, France
| | - Gérald Raverot
- Department of Endocrinology, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, "Groupement Hospitalier Est" Hospices Civils de Lyon, Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Claude-Bernard Lyon 1 University, Lyon, France
| | - Régis Coutant
- Department of Paediatric Endocrinology, Angers University Hospital, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Angers, France
| | - Philippe Chanson
- Inserm, Université Paris-Saclay, Physiologie et Physiopathologie Endocriniennes, AP-HP, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, 94270 Le Kremlin-Bicêtre, France
| | - Dulanjalee Kariyawasam
- Service d'Endocrinologie, Diabétologie, Gynécologie pédiatriques, Hôpital Universitaire Necker-Enfants-Malades, AP-HP Centre, Université Paris Cité, Paris, France
| | - Christine Poitou
- Service de Nutrition, hôpital de la Pitié-Salpêtrière, AP-HP, Sorbonne Université, Inserm, Unité Nutrition et Obésités, approches systémiques, Nutriomique, 75013 Paris, France
| | - Cécile Thomas-Teinturier
- Université Paris-Saclay, Radiation Epidemiology Team, Inserm U1018, AP-HP, Hôpital Bicêtre, Department of Pediatric Endocrinology and Diabetes, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Le Kremlin-Bicêtre, France
| | - Bertrand Baussart
- Department of Neurosurgery, AP-HP, La Pitié-Salpêtrière University Hospital, Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, France
| | - Dinane Samara-Boustani
- Department of Paediatric Endocrinology, Diabetology, Gynaecology, Necker-Enfants-Malades University Hospital, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement, Centre de référence des Pathologies Gynécologiques Rares, AP-HP Centre, 75015 Paris, France
| | - Loïc Feuvret
- Department of Radiotherapy and Neuroradiosurgery, "Groupement Hospitalier Est" Hospices Civils de Lyon, Bron, France
| | - Carine Villanueva
- Department of Paediatric Endocrinology, Centre de Référence des Maladies Rares de l'hypophyse HYPO, "Groupement Hospitalier Est" Hospices Civils de Lyon, Faculty of Medicine, Claude-Bernard Lyon 1 University, Bron, France
| | - Chiara Villa
- Department of Neuropathology, AP-HP, La Pitié-Salpêtrière University Hospital, Inserm U1016, Institut Cochin, CNRS UMR 8104, Université Paris Descartes-Université de Paris, Paris, France
| | - Benjamin Bouillet
- Department of Endocrinology, Diabetes and Metabolic Disorders, Dijon University Hospital, Inserm Unit, LNC-UMR 1231, University of Burgundy, Dijon, France
| | - Maïthé Tauber
- Centre de Référence du Syndrome de Prader-Willi et autres syndromes avec troubles du comportement alimentaire, Hôpital des Enfants, CHU de Toulouse, Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity) Inserm UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse, France
| | - Stéphanie Espiard
- University of Lille, CHU de Lille, Department of Endocrinology, Diabetology, and Metabolism, U1190 Translational Research for Diabetes, Inserm, Institut Pasteur de Lille, Lille, France
| | - Sarah Castets
- AP-HM, Multidisciplinary Pediatrics Department, Hôpital de la Timone, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Aix-Marseille Université, Inserm, U1251, Marseille Medical Genetics (MMG), Institut Marseille Maladies Rares (MarMaRa), 13005 Marseille, France
| | - Albert Beckers
- Department of Endocrinology, Centre Hospitalier Universitaire de Liège, University of Liège, Liège, Belgium
| | - Jessica Amsellem
- Department of Paediatric Endocrinology, Angers University Hospital, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Angers, France
| | - Marie-Christine Vantyghem
- University of Lille, CHU de Lille, Department of Endocrinology, Diabetology, and Metabolism, U1190 Translational Research for Diabetes, Inserm, Institut Pasteur de Lille, Lille, France
| | - Brigitte Delemer
- Department of Endocrinology, Diabetes and Nutrition, CHU de Reims, Hôpital Robert-Debré, 51100 Reims, France
| | | | - Thierry Brue
- AP-HM, Department of Endocrinology, Hôpital de la Conception, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Aix-Marseille Université, Inserm, U1251, Marseille Medical Genetics (MMG), Institut Marseille Maladies Rares (MarMaRa), 13005 Marseille, France
| | - Nicolas André
- Marseille-La Timone University Hospital, Oncologie Pédiatrique, REMAP4KIDS CRCM Inserm U1068 Aix-Marseille University, Marseille, France
| | - Véronique Kerlan
- Department of Endocrinology, University Hospital, UMR Inserm 1304 GETBO, Brest, France
| | - Thomas Graillon
- Aix-Marseille Université, Inserm, AP-HM, MMG, UMR1251, Marmara Institute, La Timone Hospital, Hospital, Neurosurgery Department, Marseille, France
| | - Isabelle Raingeard
- Department of Endocrinology, University of Montpellier, Montpellier, France
| | - Claire Alapetite
- Institut Curie, Radiation Oncology Department, Paris & Proton Center, Orsay, France
| | - Véronique Raverot
- LBMMS, Laboratoire de Biochimie et biologie moléculaire, Hospices Civils de Lyon, 69677 Lyon, France
| | - Sylvie Salenave
- Inserm, Université Paris-Saclay, Physiologie et Physiopathologie Endocriniennes, AP-HP, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, 94270 Le Kremlin-Bicêtre, France
| | - Anne Boulin
- Department of Therapeutic and Interventional Neuroradiology, Hospital Foch, Suresnes, France
| | - Romain Appay
- AP-HM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Aix-Marseille Université, CNRS, Inst Neurophysiopathol (INP), Marseille, France
| | - Florian Dalmas
- Department of Ophthalmology, Hôpital Nord, AP-HM, Marseille, France
| | - Sarah Fodil
- Department of Endocrinology, University of Montpellier, Montpellier, France
| | - Lucie Coppin
- Université de Lille, CNRS, Inserm, CHU de Lille, UMR9020-U1277 - Cancer - Heterogeneity Plasticity and Resistance to Therapies (CANTHER), Lille, France
| | - Camille Buffet
- Thyroid and Endocrine Tumors Department, Pitié-Salpêtrière Hospital, Thyroid Tumors Clinical Research Group, Sorbonne University, Cancer Institute, Inserm U1146, CNRS UMR 7371, Paris, France
| | - Philippe Thuillier
- Department of Endocrinology, University Hospital, UMR Inserm 1304 GETBO, Brest, France
| | - Frédéric Castinetti
- AP-HM, Department of Endocrinology, Hôpital de la Conception, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Aix-Marseille Université, Inserm, U1251, Marseille Medical Genetics (MMG), Institut Marseille Maladies Rares (MarMaRa), 13005 Marseille, France
| | - Guillaume Vogin
- Centre François Baclesse, Centre national de radiothérapie du Luxembourg, Université de Luxembourg, Luxembourg Institute of Health, Luxembourg, Luxembourg
| | - Laure Cazabat
- UMR 1198 BREED, équipe RHuMA, UFR Simone Veil Santé, Université Versailles Saint-Quentin-en-Yvelines, Université Paris Saclay, Service de Neurochirurgie, Hôpital Foch, Suresnes, France
| | - Emmanuelle Kuhn
- Pituitary Unit, Hôpital Pitié-Salpêtrière, AP-HP, 75013 Paris, France
| | - Magalie Haissaguerre
- Department of Endocrinology, CHU Bordeaux, Hôpital Haut Lévêque, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, Université de Bordeaux, Pessac, France
| | - Yves Reznik
- Department of Endocrinology, Diabetes, Metabolic Disorders, University Hospital Caen, Caen, France
| | - Bernard Goichot
- Service d'Endocrinologie, Diabétologie et Nutrition, Hôpitaux Universitaires de Strasbourg, 67098 Strasbourg cedex, France
| | - Anne Bachelot
- AP-HP, Pitié-Salpêtrière Hospital, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du développement, Centre de Référence des Pathologies Gynécologiques Rares, Department of Endocrinology and Reproductive Medicine, Sorbonne Université Médecine, Paris, France
| | - Peter Kamenicky
- Inserm, Université Paris-Saclay, Physiologie et Physiopathologie Endocriniennes, AP-HP, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, 94270 Le Kremlin-Bicêtre, France
| | - Bénédicte Decoudier
- Department of Endocrinology, Diabetes and Nutrition, CHU de Reims, Hôpital Robert-Debré, 51100 Reims, France
| | - Charlotte Planchon
- Neurosurgery Department A, University Hospital of Bordeaux, place Amélie-Raba-Léon, Bordeaux, France
| | - Jean-Arthur Micoulaud-Franchi
- Sleep Medicine Unit, University Hospital of Bordeaux, UMR CNRS 6033 SANPSY, University Hospital of Bordeaux, 33076 Bordeaux, France
| | - Pauline Romanet
- Aix-Marseille Université, AP-HM, Inserm, MMG, La Timone Hospital, Laboratory of molecular biology GEnOPé, Marseille, France
| | - David Jacobi
- Nantes Université, CHU de Nantes, CNRS, Inserm, L'institut du Thorax, 44000 Nantes, France
| | - Pauline Faucher
- Service de Nutrition, hôpital de la Pitié-Salpêtrière, AP-HP, Sorbonne Université, Inserm, Unité Nutrition et Obésités, approches systémiques, Nutriomique, 75013 Paris, France
| | - Claire Carette
- Nutrition Department, Georges-Pompidou Hospital, AP-HP, Paris Cité University, Paris, France
| | - Hélène Bihan
- Avicenne Hospital, Bobigny, France; Health Education and Practices Laboratory, Université Paris 13, Paris, France
| | - Delphine Drui
- Service d'endocrinologie, diabétologie et nutrition, l'institut du thorax, Nantes université, CHU de Nantes, 44000 Nantes, France
| | - Sylvie Rossignol
- Department of Paediatric Endocrinology, University Hospital of Strasbourg, Strasbourg, France
| | - Lucile Gonin
- Department of dietetics, Hôpital de la Conception, Centre de Référence des Maladies Rares de l'hypophyse HYPO, Aix-Marseille Université, Marseille, France
| | | | - Laurent Wiard
- Dispositifs UEROS/CLANA, USN Tastet Girard, CHU de Bordeaux, Bordeaux, France
| | - Carine Courtillot
- AP-HP, Pitié-Salpêtrière Hospital, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du développement, Centre de Référence des Pathologies Gynécologiques Rares, Department of Endocrinology and Reproductive Medicine, Sorbonne Université Médecine, Paris, France
| | - Marc Nicolino
- Department of Paediatric Endocrinology, Centre de Référence des Maladies Rares de l'hypophyse HYPO, "Groupement Hospitalier Est" Hospices Civils de Lyon, Faculty of Medicine, Claude-Bernard Lyon 1 University, Bron, France
| | - Solange Grunenwald
- Department of Endocrinology, Hôpital Larrey, CHU de Toulouse, 31059 Toulouse cedex 9, France
| | - Olivier Chabre
- Université Grenoble Alpes, UMR 1292 Inserm-CEA-UGA, Endocrinologie CHU Grenoble-Alpes, 38000 Grenoble, France
| | - Sophie Christin-Maître
- Sorbonne University, Department of Endocrinology, Diabetes and Reproductive Medicine, Hôpital Saint-Antoine, Center of rare diseases Endo-ERN, AP-HP, Paris, France
| | - Rachel Desailloud
- Service d'Endocrinologie-Diabétologie-Nutrition, CHUAP, Peritox_I01, UPJV/INeris, 80000 Amiens, France
| | - Dominique Maiter
- Department of Endocrinology and Nutrition, UCLouvain Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium
| | - Laurence Guignat
- Department of Endocrinology and National Reference Center for Rare Adrenal Disorders, Hôpital Cochin, Assistance publique-Hôpitaux de Paris, Paris, France
| | - Aude Brac de la Perrière
- Department of Paediatric Endocrinology, Angers University Hospital, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Angers, France
| | - Philippe Salva
- Patient National Association "Craniopharyngiome Solidarité", Tarbes, France
| | - Didier Scavarda
- Department of Neurosurgery, Hôpital La Timone Enfants, Marseille, France
| | - Fabrice Bonneville
- Department of Neuroradiology, University Hospital of Toulouse, CHU Purpan, 31000 Toulouse, France
| | - Philippe Caron
- Department of Endocrinology, Hôpital Larrey, CHU de Toulouse, 31059 Toulouse cedex 9, France
| | - Alexandre Vasiljevic
- Pathology and Neuropathology Department, Groupement Hospitalier Est, Hospices Civils de Lyon, Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Claude-Bernard Lyon 1 University, Bron, France
| | | | - Christine Cortet
- University of Lille, CHU de Lille, Department of Endocrinology, Diabetology, and Metabolism, U1190 Translational Research for Diabetes, Inserm, Institut Pasteur de Lille, Lille, France
| | - Stephan Gaillard
- Department of Neurosurgery, AP-HP, La Pitié-Salpêtrière University Hospital, Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, France
| | - Frédérique Albarel
- AP-HM, Department of Endocrinology, Hôpital de la Conception, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Aix-Marseille Université, Inserm, U1251, Marseille Medical Genetics (MMG), Institut Marseille Maladies Rares (MarMaRa), 13005 Marseille, France
| | - Karine Clément
- Service de Nutrition, hôpital de la Pitié-Salpêtrière, AP-HP, Sorbonne Université, Inserm, Unité Nutrition et Obésités, approches systémiques, Nutriomique, 75013 Paris, France
| | - Emmanuel Jouanneau
- Adult Cranial Surgery Unit Skull Base and Pituitary Surgery Reference Centre for Rare Pituitary Diseases HYPO, Reference Center for type 2 Neurofibromatosis, Claude-Bernard University, Lyon, France, "Groupement Hospitalier Est" Hospices Civils de Lyon, Bron, France
| | - Henry Dufour
- Aix-Marseille Université, Inserm, AP-HM, MMG, UMR1251, Marmara Institute, La Timone Hospital, Hospital, Neurosurgery Department, Marseille, France
| | - Pascal Barat
- Pediatric Endocrinology Unit, CHU de Bordeaux, NutriNeurO, UMR, University of Bordeaux, Bordeaux, France
| | - Blandine Gatta-Cherifi
- Department of Endocrinology, CHU Bordeaux, Hôpital Haut Lévêque, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, Université de Bordeaux, Pessac, France
| |
Collapse
|
4
|
Gosselin LE, Morin N, Gariépy C, Chamberland M, Beaulieu O, Nadeau S, Champagne PO. Development and Validation of a Novel Human-Fixed Cadaveric Model Reproducing Cerebrospinal Fluid Circulation for Simulation of Endoscopic Endonasal Skull Base Surgery. Oper Neurosurg (Hagerstown) 2025; 28:262-270. [PMID: 38995026 DOI: 10.1227/ons.0000000000001272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2024] [Accepted: 05/20/2024] [Indexed: 07/13/2024] Open
Abstract
BACKGROUND AND OBJECTIVES Endoscopic endonasal surgery is a well-established surgical approach to the skull base. Surgeons need a reusable long-lasting tool to acquire the skills needed for skull base reconstruction. The aim of this study was to elaborate and validate a human formalin-fixed cadaveric model that reproduces a realistic cerebrospinal fluid (CSF) circulation and that adequately renders a CSF leak. METHODS An external ventricular drain that connects with a peristaltic pump is placed in the subarachnoid space, which allows a water circulation that reproduces CSF circulation. Intracranial pressure is measured in real time. Endoscopic endonasal skull base approaches are performed, to create different skull base openings and CSF leaks. Participants were tasked with reconstruction of the defects using a standardized multilayered approach, with the goal of obtaining a watertight closure under normal intracranial pressure ranges. Compiled data included time of reconstruction, years of experience of participants, and success/failure to achieve a watertight reconstruction. A Likert questionnaire was also used. RESULTS The cadaveric model reproduced CSF circulation in 4 types of dural defects: sellar, suprasellar, transcribriform, and transclival. Intracranial pressures were similar to physiological conditions and were reproducible. Each model was tested multiple times, over several months. Success rates concurred with training levels (r = .8282 and P = .0017). A strong inverse correlation was also found between years of experience and time of reconstruction (r = .4977 and P < .0001). Participants agreed that the model was realistic (median Likert score of 4), and they strongly agreed that it allowed for the improvement of their surgical skills (median Likert score of 5). CONCLUSION This novel human-fixed cadaveric model for CSF circulation is efficient and adequately reproduces surgical conditions for skull base approaches. The model is unique, easy to reproduce, and reusable. It can be used as a tool for teaching and for research purposes.
Collapse
Affiliation(s)
- Laura-Elisabeth Gosselin
- Department of Otolaryngology - Head and Neck Surgery, Université Laval, Quebec , Québec , Canada
- Université Laval Neurosurgical Innovation Laboratory (ULNIL), Quebec , Québec , Canada
| | - Nicolas Morin
- Université Laval Neurosurgical Innovation Laboratory (ULNIL), Quebec , Québec , Canada
- Department of Neurosurgery, Université Laval, Quebec , Québec , Canada
| | - Charles Gariépy
- Department of Neurosurgery, Université Laval, Quebec , Québec , Canada
| | - Mathieu Chamberland
- Department of Otolaryngology - Head and Neck Surgery, Université Laval, Quebec , Québec , Canada
| | - Olivier Beaulieu
- Department of Otolaryngology - Head and Neck Surgery, Université Laval, Quebec , Québec , Canada
| | - Sylvie Nadeau
- Department of Otolaryngology - Head and Neck Surgery, Centre Hospitalier Universitaire de Québec-Université Laval, Quebec , Québec , Canada
| | - Pierre-Olivier Champagne
- Université Laval Neurosurgical Innovation Laboratory (ULNIL), Quebec , Québec , Canada
- Department of Neurosurgery, Centre Hospitalier Universitaire de Québec-Université Laval, Quebec , Québec , Canada
| |
Collapse
|
5
|
Gurses ME, Gökalp E, Gecici NN, Shah KH, Baboun SR, Eatz TA, Valdez MM, Costello MC, Roach CS, Merenzon MA, Lu VM, Shah AH, Ivan ME, Sargi Z, Komotar RJ. The learning curve and outcomes of 1038 endoscopic endonasal transsphenoidal pituitary tumor surgeries - A single surgical team experience. Surg Neurol Int 2024; 15:407. [PMID: 39640344 PMCID: PMC11618761 DOI: 10.25259/sni_750_2024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2024] [Accepted: 10/11/2024] [Indexed: 12/07/2024] Open
Abstract
Background Pituitary adenomas rank third among adult intracranial tumors, with an incidence of 3.9- 7.4 cases/per 100,000 annually. Transsphenoidal surgery has evolved to include endoscopic endonasal surgery (EEA) in many centers due to technological and surgical advancements over the past two decades. We aim to analyze a 12-year cohort of pituitary adenomas operated through EEA, highlighting the evolution of surgical techniques and outcomes. Methods A retrospective review of patients undergoing EEA was conducted. A team of an otolaryngologist and neurosurgeon performed surgeries. The cohort was divided into three groups: Phase 1 (P1, 2012-2015), Phase 2 (P2, 2016-2019), and Phase 3 (P3, 2020-2023). Patient demographics, clinical data, and outcomes were collected from electronic medical records and compared over time. Results The mean age was 54.2 years, with 53.5% being female. The gross total resection rate was 75.6%, increasing from 62.3% in P1 to 76.3% in P3 (P = 0.003). The mean operative duration was 274.61 min, with no significant correlation to case number. Complication rates, excluding cerebrospinal fluid (CSF) leaks, were similar between the groups, with no statistically significant differences observed for complications such as visual deficit, cranial nerve palsy, and epistaxis. However, meningitis decreased significantly from 3.8% to 0.3% (P < 0.001). Intraoperative CSF leaks decreased from 65.1% to 55% (P = 0.003). The need for revision surgery was lower in P3 (8.5% vs. 5.4% vs. 2.1, P < 0.001). Length of hospitalization decreased from 5.3 days to 3.9 days (P < 0.001). Conclusion Our experience with EEA for pituitary adenomas shows significant improvements in surgical outcomes, reduced complications, and better postoperative management, underscoring the importance of experience, technical refinement, and a multidisciplinary approach.
Collapse
Affiliation(s)
- Muhammet Enes Gurses
- Department of Neurological Surgery, University of Miami, Miller School of Medicine, Lois Pope Life Center, Miami, United States
| | - Elif Gökalp
- Department of Neurological Surgery,University of Southern California, Los Angeles, CA, United States
| | - Neslihan Nisa Gecici
- Department of Neurological Surgery, University of Miami, Miller School of Medicine, Lois Pope Life Center, Miami, United States
| | - Khushi Hemendra Shah
- Department of Neurological Surgery, University of Miami, Miller School of Medicine, Lois Pope Life Center, Miami, United States
| | - Stephanie Rose Baboun
- Department of Neurological Surgery, University of Miami, Miller School of Medicine, Lois Pope Life Center, Miami, United States
| | - Tiffany Alyssa Eatz
- Department of Neurological Surgery, University of Miami, Miller School of Medicine, Lois Pope Life Center, Miami, United States
| | - Mynor Mendez Valdez
- Department of Otolaryngology, University of Miami, Miller School of Medicine, Lois Pope Life Center, Miami, United States
| | - Meredith Claire Costello
- Department of Neurological Surgery, University of Miami, Miller School of Medicine, Lois Pope Life Center, Miami, United States
| | - Caleigh Samantha Roach
- Department of Neurological Surgery, University of Miami, Miller School of Medicine, Lois Pope Life Center, Miami, United States
| | - Martin A. Merenzon
- Department of Neurological Surgery, University of Miami, Miller School of Medicine, Lois Pope Life Center, Miami, United States
| | - Victor M. Lu
- Department of Neurological Surgery, University of Miami, Miller School of Medicine, Lois Pope Life Center, Miami, United States
| | - Ashish H. Shah
- Department of Neurological Surgery, University of Miami, Miller School of Medicine, Lois Pope Life Center, Miami, United States
| | - Michael E. Ivan
- Department of Neurological Surgery, University of Miami, Miller School of Medicine, Lois Pope Life Center, Miami, United States
| | - Zoukaa Sargi
- Department of Otolaryngology, University of Miami, Miller School of Medicine, Lois Pope Life Center, Miami, United States
| | - Ricardo J. Komotar
- Department of Neurological Surgery, University of Miami, Miller School of Medicine, Lois Pope Life Center, Miami, United States
| |
Collapse
|
6
|
Potter GM, Siripurapu R, Herwadkar A, Abdulla S, Ikotun O, Broadhurst P, Woodward M, Bhalla RK, Glancz LJ, Hammerbeck-Ward CL, Rutherford SA, Pathmanaban ON, Roncaroli F, Colaco RJ, Pan S, Whitfield GA. Skull Base Chordoma and Chondrosarcoma: Neuroradiologist's Guide to Diagnosis, Surgical Management, and Proton Beam Therapy. Radiographics 2024; 44:e240036. [PMID: 39298353 DOI: 10.1148/rg.240036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/21/2024]
Abstract
Skull base chordomas and chondrosarcomas are distinct types of rare, locally aggressive mesenchymal tumors that share key principles of imaging investigation and multidisciplinary care. Maximal safe surgical resection is the treatment choice for each, often via an expanded endoscopic endonasal approach, with or without multilayer skull base repair. Postoperative adjuvant radiation therapy is frequently administered, usually with particle therapy such as proton beam therapy (PBT). Compared with photon therapy, PBT enables dose escalation while limiting damage to dose-limiting neurologic structures, particularly the brainstem and optic apparatus, due to energy deposition being delivered at a high maximum with a rapid decrease at the end of the penetration range (Bragg peak phenomenon). Essential requirements for PBT following gross total or maximal safe resection are tissue diagnosis, minimal residual tumor after resection, and adequate clearance from PBT dose-limiting structures. The radiologist should understand surgical approaches and surgical techniques, including multilayer skull base repair, and be aware of evolution of postsurgical imaging appearances over time. Accurate radiologic review of all relevant preoperative imaging examinations and of intraoperative and postoperative MRI examinations plays a key role in management. The radiology report should reflect what the skull base surgeon and radiation oncologist need to know, including distance between the tumor and PBT dose-limiting structures, tumor sites that may be difficult to access via the endoscopic endonasal route, the relationship between intradural tumor and neurovascular structures, and tumor sites with implications for postresection stability. ©RSNA, 2024 Supplemental material is available for this article.
Collapse
Affiliation(s)
- Gillian M Potter
- From the Department of Radiology (G.M.P., P.B., M.W.) and ENT Surgery (R.K.B.), Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom M13 9WL; Department of Neuroradiology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom (R.S.); Department of Radiology, Salford Royal Hospital, Salford, United Kingdom (A.H., S.A.); Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom (S.A.R., O.N.P.); University Hospital Lewisham, London, United Kingdom (O.I.); Department of Neurosurgery, Queen's Medical Centre, Nottinghamshire, United Kingdom and University of Nottingham, Nottingham, United Kingdom (L.J.G.); Department of Neurosurgery, Royal Sussex County Hospital Brighton, United Kingdom (C.L.H-W.); Division of Neuroscience (F.R.) and Division of Cancer Sciences (G.A.W.), University of Manchester, Manchester, United Kingdom; and Department of Clinical Oncology, Christie Hospital, Manchester, United Kingdom (R.J.C., S.P., G.A.W.)
| | - Rekha Siripurapu
- From the Department of Radiology (G.M.P., P.B., M.W.) and ENT Surgery (R.K.B.), Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom M13 9WL; Department of Neuroradiology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom (R.S.); Department of Radiology, Salford Royal Hospital, Salford, United Kingdom (A.H., S.A.); Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom (S.A.R., O.N.P.); University Hospital Lewisham, London, United Kingdom (O.I.); Department of Neurosurgery, Queen's Medical Centre, Nottinghamshire, United Kingdom and University of Nottingham, Nottingham, United Kingdom (L.J.G.); Department of Neurosurgery, Royal Sussex County Hospital Brighton, United Kingdom (C.L.H-W.); Division of Neuroscience (F.R.) and Division of Cancer Sciences (G.A.W.), University of Manchester, Manchester, United Kingdom; and Department of Clinical Oncology, Christie Hospital, Manchester, United Kingdom (R.J.C., S.P., G.A.W.)
| | - Amit Herwadkar
- From the Department of Radiology (G.M.P., P.B., M.W.) and ENT Surgery (R.K.B.), Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom M13 9WL; Department of Neuroradiology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom (R.S.); Department of Radiology, Salford Royal Hospital, Salford, United Kingdom (A.H., S.A.); Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom (S.A.R., O.N.P.); University Hospital Lewisham, London, United Kingdom (O.I.); Department of Neurosurgery, Queen's Medical Centre, Nottinghamshire, United Kingdom and University of Nottingham, Nottingham, United Kingdom (L.J.G.); Department of Neurosurgery, Royal Sussex County Hospital Brighton, United Kingdom (C.L.H-W.); Division of Neuroscience (F.R.) and Division of Cancer Sciences (G.A.W.), University of Manchester, Manchester, United Kingdom; and Department of Clinical Oncology, Christie Hospital, Manchester, United Kingdom (R.J.C., S.P., G.A.W.)
| | - Sarah Abdulla
- From the Department of Radiology (G.M.P., P.B., M.W.) and ENT Surgery (R.K.B.), Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom M13 9WL; Department of Neuroradiology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom (R.S.); Department of Radiology, Salford Royal Hospital, Salford, United Kingdom (A.H., S.A.); Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom (S.A.R., O.N.P.); University Hospital Lewisham, London, United Kingdom (O.I.); Department of Neurosurgery, Queen's Medical Centre, Nottinghamshire, United Kingdom and University of Nottingham, Nottingham, United Kingdom (L.J.G.); Department of Neurosurgery, Royal Sussex County Hospital Brighton, United Kingdom (C.L.H-W.); Division of Neuroscience (F.R.) and Division of Cancer Sciences (G.A.W.), University of Manchester, Manchester, United Kingdom; and Department of Clinical Oncology, Christie Hospital, Manchester, United Kingdom (R.J.C., S.P., G.A.W.)
| | - Oluwaseun Ikotun
- From the Department of Radiology (G.M.P., P.B., M.W.) and ENT Surgery (R.K.B.), Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom M13 9WL; Department of Neuroradiology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom (R.S.); Department of Radiology, Salford Royal Hospital, Salford, United Kingdom (A.H., S.A.); Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom (S.A.R., O.N.P.); University Hospital Lewisham, London, United Kingdom (O.I.); Department of Neurosurgery, Queen's Medical Centre, Nottinghamshire, United Kingdom and University of Nottingham, Nottingham, United Kingdom (L.J.G.); Department of Neurosurgery, Royal Sussex County Hospital Brighton, United Kingdom (C.L.H-W.); Division of Neuroscience (F.R.) and Division of Cancer Sciences (G.A.W.), University of Manchester, Manchester, United Kingdom; and Department of Clinical Oncology, Christie Hospital, Manchester, United Kingdom (R.J.C., S.P., G.A.W.)
| | - Philip Broadhurst
- From the Department of Radiology (G.M.P., P.B., M.W.) and ENT Surgery (R.K.B.), Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom M13 9WL; Department of Neuroradiology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom (R.S.); Department of Radiology, Salford Royal Hospital, Salford, United Kingdom (A.H., S.A.); Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom (S.A.R., O.N.P.); University Hospital Lewisham, London, United Kingdom (O.I.); Department of Neurosurgery, Queen's Medical Centre, Nottinghamshire, United Kingdom and University of Nottingham, Nottingham, United Kingdom (L.J.G.); Department of Neurosurgery, Royal Sussex County Hospital Brighton, United Kingdom (C.L.H-W.); Division of Neuroscience (F.R.) and Division of Cancer Sciences (G.A.W.), University of Manchester, Manchester, United Kingdom; and Department of Clinical Oncology, Christie Hospital, Manchester, United Kingdom (R.J.C., S.P., G.A.W.)
| | - Mark Woodward
- From the Department of Radiology (G.M.P., P.B., M.W.) and ENT Surgery (R.K.B.), Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom M13 9WL; Department of Neuroradiology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom (R.S.); Department of Radiology, Salford Royal Hospital, Salford, United Kingdom (A.H., S.A.); Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom (S.A.R., O.N.P.); University Hospital Lewisham, London, United Kingdom (O.I.); Department of Neurosurgery, Queen's Medical Centre, Nottinghamshire, United Kingdom and University of Nottingham, Nottingham, United Kingdom (L.J.G.); Department of Neurosurgery, Royal Sussex County Hospital Brighton, United Kingdom (C.L.H-W.); Division of Neuroscience (F.R.) and Division of Cancer Sciences (G.A.W.), University of Manchester, Manchester, United Kingdom; and Department of Clinical Oncology, Christie Hospital, Manchester, United Kingdom (R.J.C., S.P., G.A.W.)
| | - Rajiv K Bhalla
- From the Department of Radiology (G.M.P., P.B., M.W.) and ENT Surgery (R.K.B.), Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom M13 9WL; Department of Neuroradiology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom (R.S.); Department of Radiology, Salford Royal Hospital, Salford, United Kingdom (A.H., S.A.); Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom (S.A.R., O.N.P.); University Hospital Lewisham, London, United Kingdom (O.I.); Department of Neurosurgery, Queen's Medical Centre, Nottinghamshire, United Kingdom and University of Nottingham, Nottingham, United Kingdom (L.J.G.); Department of Neurosurgery, Royal Sussex County Hospital Brighton, United Kingdom (C.L.H-W.); Division of Neuroscience (F.R.) and Division of Cancer Sciences (G.A.W.), University of Manchester, Manchester, United Kingdom; and Department of Clinical Oncology, Christie Hospital, Manchester, United Kingdom (R.J.C., S.P., G.A.W.)
| | - Laurence J Glancz
- From the Department of Radiology (G.M.P., P.B., M.W.) and ENT Surgery (R.K.B.), Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom M13 9WL; Department of Neuroradiology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom (R.S.); Department of Radiology, Salford Royal Hospital, Salford, United Kingdom (A.H., S.A.); Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom (S.A.R., O.N.P.); University Hospital Lewisham, London, United Kingdom (O.I.); Department of Neurosurgery, Queen's Medical Centre, Nottinghamshire, United Kingdom and University of Nottingham, Nottingham, United Kingdom (L.J.G.); Department of Neurosurgery, Royal Sussex County Hospital Brighton, United Kingdom (C.L.H-W.); Division of Neuroscience (F.R.) and Division of Cancer Sciences (G.A.W.), University of Manchester, Manchester, United Kingdom; and Department of Clinical Oncology, Christie Hospital, Manchester, United Kingdom (R.J.C., S.P., G.A.W.)
| | - Charlotte L Hammerbeck-Ward
- From the Department of Radiology (G.M.P., P.B., M.W.) and ENT Surgery (R.K.B.), Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom M13 9WL; Department of Neuroradiology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom (R.S.); Department of Radiology, Salford Royal Hospital, Salford, United Kingdom (A.H., S.A.); Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom (S.A.R., O.N.P.); University Hospital Lewisham, London, United Kingdom (O.I.); Department of Neurosurgery, Queen's Medical Centre, Nottinghamshire, United Kingdom and University of Nottingham, Nottingham, United Kingdom (L.J.G.); Department of Neurosurgery, Royal Sussex County Hospital Brighton, United Kingdom (C.L.H-W.); Division of Neuroscience (F.R.) and Division of Cancer Sciences (G.A.W.), University of Manchester, Manchester, United Kingdom; and Department of Clinical Oncology, Christie Hospital, Manchester, United Kingdom (R.J.C., S.P., G.A.W.)
| | - Scott A Rutherford
- From the Department of Radiology (G.M.P., P.B., M.W.) and ENT Surgery (R.K.B.), Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom M13 9WL; Department of Neuroradiology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom (R.S.); Department of Radiology, Salford Royal Hospital, Salford, United Kingdom (A.H., S.A.); Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom (S.A.R., O.N.P.); University Hospital Lewisham, London, United Kingdom (O.I.); Department of Neurosurgery, Queen's Medical Centre, Nottinghamshire, United Kingdom and University of Nottingham, Nottingham, United Kingdom (L.J.G.); Department of Neurosurgery, Royal Sussex County Hospital Brighton, United Kingdom (C.L.H-W.); Division of Neuroscience (F.R.) and Division of Cancer Sciences (G.A.W.), University of Manchester, Manchester, United Kingdom; and Department of Clinical Oncology, Christie Hospital, Manchester, United Kingdom (R.J.C., S.P., G.A.W.)
| | - Omar N Pathmanaban
- From the Department of Radiology (G.M.P., P.B., M.W.) and ENT Surgery (R.K.B.), Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom M13 9WL; Department of Neuroradiology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom (R.S.); Department of Radiology, Salford Royal Hospital, Salford, United Kingdom (A.H., S.A.); Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom (S.A.R., O.N.P.); University Hospital Lewisham, London, United Kingdom (O.I.); Department of Neurosurgery, Queen's Medical Centre, Nottinghamshire, United Kingdom and University of Nottingham, Nottingham, United Kingdom (L.J.G.); Department of Neurosurgery, Royal Sussex County Hospital Brighton, United Kingdom (C.L.H-W.); Division of Neuroscience (F.R.) and Division of Cancer Sciences (G.A.W.), University of Manchester, Manchester, United Kingdom; and Department of Clinical Oncology, Christie Hospital, Manchester, United Kingdom (R.J.C., S.P., G.A.W.)
| | - Federico Roncaroli
- From the Department of Radiology (G.M.P., P.B., M.W.) and ENT Surgery (R.K.B.), Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom M13 9WL; Department of Neuroradiology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom (R.S.); Department of Radiology, Salford Royal Hospital, Salford, United Kingdom (A.H., S.A.); Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom (S.A.R., O.N.P.); University Hospital Lewisham, London, United Kingdom (O.I.); Department of Neurosurgery, Queen's Medical Centre, Nottinghamshire, United Kingdom and University of Nottingham, Nottingham, United Kingdom (L.J.G.); Department of Neurosurgery, Royal Sussex County Hospital Brighton, United Kingdom (C.L.H-W.); Division of Neuroscience (F.R.) and Division of Cancer Sciences (G.A.W.), University of Manchester, Manchester, United Kingdom; and Department of Clinical Oncology, Christie Hospital, Manchester, United Kingdom (R.J.C., S.P., G.A.W.)
| | - Rovel J Colaco
- From the Department of Radiology (G.M.P., P.B., M.W.) and ENT Surgery (R.K.B.), Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom M13 9WL; Department of Neuroradiology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom (R.S.); Department of Radiology, Salford Royal Hospital, Salford, United Kingdom (A.H., S.A.); Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom (S.A.R., O.N.P.); University Hospital Lewisham, London, United Kingdom (O.I.); Department of Neurosurgery, Queen's Medical Centre, Nottinghamshire, United Kingdom and University of Nottingham, Nottingham, United Kingdom (L.J.G.); Department of Neurosurgery, Royal Sussex County Hospital Brighton, United Kingdom (C.L.H-W.); Division of Neuroscience (F.R.) and Division of Cancer Sciences (G.A.W.), University of Manchester, Manchester, United Kingdom; and Department of Clinical Oncology, Christie Hospital, Manchester, United Kingdom (R.J.C., S.P., G.A.W.)
| | - Shermaine Pan
- From the Department of Radiology (G.M.P., P.B., M.W.) and ENT Surgery (R.K.B.), Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom M13 9WL; Department of Neuroradiology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom (R.S.); Department of Radiology, Salford Royal Hospital, Salford, United Kingdom (A.H., S.A.); Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom (S.A.R., O.N.P.); University Hospital Lewisham, London, United Kingdom (O.I.); Department of Neurosurgery, Queen's Medical Centre, Nottinghamshire, United Kingdom and University of Nottingham, Nottingham, United Kingdom (L.J.G.); Department of Neurosurgery, Royal Sussex County Hospital Brighton, United Kingdom (C.L.H-W.); Division of Neuroscience (F.R.) and Division of Cancer Sciences (G.A.W.), University of Manchester, Manchester, United Kingdom; and Department of Clinical Oncology, Christie Hospital, Manchester, United Kingdom (R.J.C., S.P., G.A.W.)
| | - Gillian A Whitfield
- From the Department of Radiology (G.M.P., P.B., M.W.) and ENT Surgery (R.K.B.), Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom M13 9WL; Department of Neuroradiology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom (R.S.); Department of Radiology, Salford Royal Hospital, Salford, United Kingdom (A.H., S.A.); Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom (S.A.R., O.N.P.); University Hospital Lewisham, London, United Kingdom (O.I.); Department of Neurosurgery, Queen's Medical Centre, Nottinghamshire, United Kingdom and University of Nottingham, Nottingham, United Kingdom (L.J.G.); Department of Neurosurgery, Royal Sussex County Hospital Brighton, United Kingdom (C.L.H-W.); Division of Neuroscience (F.R.) and Division of Cancer Sciences (G.A.W.), University of Manchester, Manchester, United Kingdom; and Department of Clinical Oncology, Christie Hospital, Manchester, United Kingdom (R.J.C., S.P., G.A.W.)
| |
Collapse
|
7
|
Gaillard S, Benichi S, Villa C, Jouinot A, Vatier C, Christin-Maitre S, Raffin-Sanson ML, Jacob J, Chanson P, Courtillot C, Bachelot A, Bertherat J, Assié G, Baussart B. Prognostic Impact of Hypothalamic Perforation in Adult Patients With Craniopharyngioma: A Cohort Study. J Clin Endocrinol Metab 2024; 109:2083-2096. [PMID: 38287910 DOI: 10.1210/clinem/dgae049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/08/2023] [Revised: 12/27/2023] [Accepted: 01/23/2024] [Indexed: 01/31/2024]
Abstract
CONTEXT Outcome of craniopharyngioma is related to its locoregional extension, which impacts resectability and the risk of surgical complications. To maximize resection and minimize complications, optic tract localization, temporal lobe extension, and hypothalamic involvement are essential factors for surgical management. OBJECTIVE To assess the outcome of craniopharyngiomas depending on their relation to the hypothalamus location. METHODS We conducted a retrospective analysis of 79 patients with a craniopharyngioma who underwent surgery from 2007 to 2022. Craniopharyngiomas were classified in 3 groups, depending on the type of hypothalamus involvement assessed by preoperative magnetic resonance imaging: infra-hypothalamic (type A, n = 33); perforating the hypothalamus (type B, n = 40); and supra-hypothalamic (type C, n = 6). Surgical strategy was guided by the type of hypothalamic involvement, favoring endonasal approaches for type A and type B, and transcranial approaches for type C. RESULTS Long-term disease control was achieved in 33/33 (100%), 37/40 (92%), and 5/6 (83%) patients in type A, B, and C, respectively. In type B, vision was improved in 32/36 (89%) patients, while hypothalamic function was improved, stable, or worsened in 6/40 (15%), 32/40 (80%), and 2/40 (5%) patients, respectively. Papillary craniopharyngiomas were found in 5/33 (15%), 9/40 (22%), and 3/6 (50%) patients in types A, B, and C, respectively. In 4 patients, BRAF/MEK inhibitors were used, with significant tumor shrinkage in all cases. CONCLUSION Craniopharyngiomas located below the hypothalamus or perforating it can be safely treated by transsphenoidal surgery. For supra-hypothalamic craniopharyngiomas, postoperative results are less favorable, and documenting a BRAF mutation may improve outcome, if targeted therapy was efficient enough to replace surgical debulking.
Collapse
Affiliation(s)
- Stephan Gaillard
- Department of Neurosurgery, Assistance Publique-Hôpitaux de Paris, La Pitié-Salpêtrière University Hospital, 75013 Paris, France
| | - Sandro Benichi
- Department of Neurosurgery, Assistance Publique-Hôpitaux de Paris, Necker University Hospital, 75015 Paris, France
| | - Chiara Villa
- CNRS, INSERM, Institut Cochin, Université Paris Cité, 75014 Paris, France
- Department of Neuropathology, Assistance Publique-Hôpitaux de Paris, La Pitié-Salpêtrière University Hospital, 75013 Paris, France
| | - Anne Jouinot
- CNRS, INSERM, Institut Cochin, Université Paris Cité, 75014 Paris, France
| | - Camille Vatier
- Endocrine Unit, Reproductive Medicine, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRMERC), Endo-ERN (ID 739527), Saint-Antoine Hospital, Sorbonne University, AP-HP, 75012 Paris, France
- INSERM UMRS938, Saint-Antoine Research Center, Sorbonne University, 75012 Paris, France
| | - Sophie Christin-Maitre
- Endocrine Unit, Reproductive Medicine, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRMERC), Endo-ERN (ID 739527), Saint-Antoine Hospital, Sorbonne University, AP-HP, 75012 Paris, France
- INSERM UMR-833, Trousseau Hospital, 75012 Paris, France
| | - Marie-Laure Raffin-Sanson
- Department of Endocrinology, Assistance Publique-Hôpitaux de Paris, Hôpital Ambroise Paré, 92100 Boulogne Billancourt, France
- Université de Versailles Saint-Quentin-en-Yvelines UFR des Sciences de la Santé Simone Veil, 78180 Montigny-le-Bretonneux, France
| | - Julian Jacob
- Radiation Oncology Department, Assistance Publique-Hôpitaux de Paris, La Pitié-Salpêtrière University Hospital, Sorbonne University, 75013 Paris, France
| | - Philippe Chanson
- Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse, Université Paris-Saclay, 94270 Le Kremlin-Bicêtre, France
- Faculté de Médecine, Inserm UMR_1185, Physiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, 94270 Le Kremlin-Bicêtre, France
| | - Carine Courtillot
- Department of Endocrinology and Reproductive Medicine, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement, CRMERC, Endo-ERN, Pitié-Salpêtrière Hospital, Sorbonne University, AP-HP, 75013 Paris, France
| | - Anne Bachelot
- Department of Endocrinology and Reproductive Medicine, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement, CRMERC, Endo-ERN, Pitié-Salpêtrière Hospital, Sorbonne University, AP-HP, 75013 Paris, France
| | - Jérôme Bertherat
- CNRS, INSERM, Institut Cochin, Université Paris Cité, 75014 Paris, France
- Department of Endocrinology, Center for Rare Adrenal Diseases, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, 75014 Paris, France
| | - Guillaume Assié
- CNRS, INSERM, Institut Cochin, Université Paris Cité, 75014 Paris, France
- Department of Endocrinology, Center for Rare Adrenal Diseases, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, 75014 Paris, France
| | - Bertrand Baussart
- Department of Neurosurgery, Assistance Publique-Hôpitaux de Paris, La Pitié-Salpêtrière University Hospital, 75013 Paris, France
- CNRS, INSERM, Institut Cochin, Université Paris Cité, 75014 Paris, France
| |
Collapse
|
8
|
Fukuhara N, Nishihara T, Sato K, Inoshita N, Tatsushima K, Yamaguchi-Okada M, Ishojima T, Takeshita A, Ito J, Takeuchi Y, Yamada S, Nishioka H. Long-term outcomes of neuroendoscopic cyst partial resection combined with stereotactic radiotherapy for craniopharyngioma. Acta Neurochir (Wien) 2024; 166:218. [PMID: 38750340 DOI: 10.1007/s00701-024-06113-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2024] [Accepted: 05/05/2024] [Indexed: 02/23/2025]
Abstract
PURPOSE The aim of this study was to evaluate the treatment outcomes of neuroendoscopic cyst partial resection (ECPR) combined with stereotactic radiotherapy (SRT) for cystic craniopharyngiomas. METHODS In this retrospective study, 22 craniopharyngioma patients undergoing ECPR combined with SRT were included. This combination therapy was indicated for suprasellar cystic craniopharyngiomas in patients whose pituitary function was preserved but would be difficult to preserve in direct surgery. The outcomes of combination therapy, including tumor control and postoperative visual and pituitary functions, were investigated. RESULTS ECPR was safely performed, and cyst shrinkage was accomplished in all cases. After ECPR, visual function improved in 12 of 13 patients (92%) with visual field disturbance and did not deteriorate in any patients. Pituitary function was preserved in 14 patients (64%) and deteriorated in eight patients (36%) after ECPR. As a complication of ECPR, meningitis occurred because of a wound infection in one patient. In 18 of 22 patients (82%), the tumor was controlled without further treatment 19 - 87 months (median, 33 months) after SRT. Hypopituitarism was an adverse event after SRT in two of the 18 patients who achieved tumor control. Four patients (18%) had enlarged cysts after SRT. Postoperative pituitary function was significantly more likely to deteriorate in cases of extensive detachment from the ventricular wall, and retreatment was significantly more common in cases with hypothalamic extension. CONCLUSION Although limited to some cases, ECPR combined with SRT is a less invasive and useful therapeutic option for suprasellar cystic craniopharyngiomas. However, its long-term prognosis requires further evaluation.
Collapse
Affiliation(s)
- Noriaki Fukuhara
- Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Minato-Ku, Tokyo, Japan.
- Okinaka Memorial Institute for Medical Research, Minato-Ku, Tokyo, Japan.
| | - Tetsuhiro Nishihara
- Internal medicine and neurosurgery Nishihara clinic, Adachi-Ku, Tokyo, Japan
| | - Kengo Sato
- CyberKnife Center, Okayama Kyokuto Hospital, Okayama, Japan
| | - Naoko Inoshita
- Okinaka Memorial Institute for Medical Research, Minato-Ku, Tokyo, Japan
- Department of Pathology, Moriyama Memorial Hospital, Edogawa-Ku, Tokyo, Japan
- Department of Pathology, Toranomon Hospital, Minato-Ku, Tokyo, Japan
| | - Keita Tatsushima
- Department of Endocrinology and Metabolism, Toranomon Hospital, Minato-Ku, Tokyo, Japan
| | - Mitsuo Yamaguchi-Okada
- Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Minato-Ku, Tokyo, Japan
| | - Tsuyoshi Ishojima
- Okinaka Memorial Institute for Medical Research, Minato-Ku, Tokyo, Japan
- Department of Pediatrics, Toranomon Hospital, Minato-Ku, Tokyo, Japan
| | - Akira Takeshita
- Okinaka Memorial Institute for Medical Research, Minato-Ku, Tokyo, Japan
- Department of Endocrinology and Metabolism, Toranomon Hospital, Minato-Ku, Tokyo, Japan
| | - Junko Ito
- Department of Pediatrics, Toranomon Hospital, Minato-Ku, Tokyo, Japan
| | - Yasuhiro Takeuchi
- Okinaka Memorial Institute for Medical Research, Minato-Ku, Tokyo, Japan
- Department of Endocrinology and Metabolism, Toranomon Hospital, Minato-Ku, Tokyo, Japan
| | - Shozo Yamada
- Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Minato-Ku, Tokyo, Japan
- Okinaka Memorial Institute for Medical Research, Minato-Ku, Tokyo, Japan
- Hypothalamic and Pituitary Center, Moriyama Memorial Hospital, Edogawa-Ku, Tokyo, Japan
| | - Hiroshi Nishioka
- Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Minato-Ku, Tokyo, Japan
- Okinaka Memorial Institute for Medical Research, Minato-Ku, Tokyo, Japan
| |
Collapse
|
9
|
De Simone M, Zoia C, Choucha A, Kong DS, De Maria L. The Transorbital Approach: A Comprehensive Review of Targets, Surgical Techniques, and Multiportal Variants. J Clin Med 2024; 13:2712. [PMID: 38731240 PMCID: PMC11084817 DOI: 10.3390/jcm13092712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2024] [Revised: 04/24/2024] [Accepted: 05/02/2024] [Indexed: 05/13/2024] Open
Abstract
The transorbital approach (TOA) is gaining popularity in skull base surgery scenarios. This approach represents a valuable surgical corridor to access various compartments and safely address several intracranial pathologies, both intradurally and extradurally, including tumors of the olfactory groove in the anterior cranial fossa (ACF), cavernous sinus in the middle cranial fossa (MCF), and the cerebellopontine angle in the posterior cranial fossa (PCF). The TOA exists in many variants, both from the point of view of invasiveness and from that of the entry point to the orbit, corresponding to the four orbital quadrants: the superior eyelid crease (SLC), the precaruncular (PC), the lateral retrocanthal (LRC), and the preseptal lower eyelid (PS). Moreover, multiportal variants, consisting of the combination of the transorbital approach with others, exist and are relevant to reach peculiar surgical territories. The significance of the TOA in neurosurgery, coupled with the dearth of thorough studies assessing its various applications and adaptations, underscores the necessity for this research. This extensive review delineates the multitude of target lesions reachable through the transorbital route, categorizing them based on surgical complexity. Furthermore, it provides an overview of the different transorbital variations, both standalone and in conjunction with other techniques. By offering a comprehensive understanding, this study aims to enhance awareness and knowledge regarding the current utility of the transorbital approach in neurosurgery. Additionally, it aims to steer future investigations toward deeper exploration, refinement, and exploration of additional perspectives concerning this surgical method.
Collapse
Affiliation(s)
- Matteo De Simone
- Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno, Via S. Allende, 84081 Baronissi, Italy
| | - Cesare Zoia
- UOC of Neurosurgery, Ospedale Moriggia Pelascini, Gravedona e Uniti, 22015 Gravedona, Italy;
| | - Anis Choucha
- Department of Neurosurgery, Aix Marseille University, APHM, UH Timone, 13005 Marseille, France;
- Laboratory of Biomechanics and Application, UMRT24, Gustave Eiffel University, Aix Marseille University, 13005 Marseille, France
| | - Doo-Sik Kong
- Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea;
| | - Lucio De Maria
- Division of Neurosurgery, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Piazza Spedali Civili 1, 25123 Brescia, Italy;
- Division of Neurosurgery, Department of Clinical Neurosciences, Geneva University Hospitals (HUG), Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland
| |
Collapse
|
10
|
Gerlach R, Modesti CL, Rampinelli V. Interdisciplinary Management of Skull Base Tumors. Laryngorhinootologie 2024; 103:S28-S42. [PMID: 38697142 DOI: 10.1055/a-2196-8984] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/04/2024]
Abstract
OBJECTIVE Endoscopic endonasal skull base surgery has gained acceptance worldwide. Comparative analysis has demonstrated that endoscopic skull base surgery may have advantages for many pathologies of the anterior skull base, e. g., sinonasal malignant tumors; pathologies of the central skull base, e. g., pituitary adenomas, craniopharyngiomas; well-selected cases of planum sphenoidale and tuberculum sellae meningiomas; or for clival lesions, e. g., chordomas, chondrosarcomas, or selected meningiomas. Over the past three decades, interdisciplinary surgical teams, consisting of otolaryngologists and neurosurgeons, have provided detailed anatomical knowledge, suggested new approaches or modifications of established surgical techniques, and offered continued surgical education. METHOD A review of pertinent literature was conducted with an emphasis on interdisciplinary endoscopic surgery of skull base lesions. RESULTS Based on the authors̓ surgical experience in two different interdisciplinary endoscopic skull base centers, the authors classify approaches for endoscopic endonasal skull base surgery, describe indications, and key anatomic landmarks for common pathologies, and highlight surgical techniques to avoid complications. CONCLUSION Interdisciplinary endonasal endoscopic surgery combines surgical expertise, improves resection rates for many pathologies, and minimizes morbidity by reducing the incidence of surgical complications.
Collapse
Affiliation(s)
| | - Claudia Lodovica Modesti
- Unit of Otolaryngology and Head and Surgery, ASST Spedali Civili di Brescia, University of Brescia, Italy
| | - Vittorio Rampinelli
- Unit of Otolaryngology and Head and Surgery, ASST Spedali Civili di Brescia, University of Brescia, Italy
| |
Collapse
|
11
|
Ravindran PK, Keizer ME, Kunst HDPM, Compter I, Van Aalst J, Eekers DBP, Temel Y. Skull-Base Chondrosarcoma: A Systematic Review of the Role of Postoperative Radiotherapy. Cancers (Basel) 2024; 16:856. [PMID: 38473218 DOI: 10.3390/cancers16050856] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2023] [Revised: 02/12/2024] [Accepted: 02/14/2024] [Indexed: 03/14/2024] Open
Abstract
Surgery and radiotherapy are key elements to the treatment of skull-base chondrosarcomas; however, there is currently no consensus regarding whether or not adjuvant radiotherapy has to be administered. This study searched the EMBASE, Cochrane, and PubMed databases for clinical studies evaluating the long-term prognosis of surgery with or without adjuvant radiotherapy. After reviewing the search results, a total of 22 articles were selected for this review. A total of 1388 patients were included in this cohort, of which 186 received surgery only. With mean follow-up periods ranging from 39.1 to 86 months, surgical treatment provided progression-free survival (PFS) rates ranging from 83.7 to 92.9% at 3 years, 60.0 to 92.9% at 5 years, and 58.2 to 64.0% at 10 years. Postoperative radiotherapy provides PFS rates ranging between 87 and 96.2% at 3 years, 57.1 and 100% at 5 years, and 67 and 100% at 10 years. Recurrence rates varied from 5.3% to 39.0% in the surgery-only approach and between 1.5% and 42.90% for the postoperative radiotherapy group. When considering prognostic variables, higher age, brainstem/optic apparatus compression, and larger tumor volume prior to radiotherapy were found to be significant factors for local recurrence.
Collapse
Affiliation(s)
- Pawan Kishore Ravindran
- Department of Neurosurgery, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands
- Dutch Academic Alliance Skull Base Pathology, Maastricht University Medical Center+, Radboud University Medical Center, 6229 HX Maastricht, The Netherlands
| | - Max E Keizer
- Department of Neurosurgery, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands
- Dutch Academic Alliance Skull Base Pathology, Maastricht University Medical Center+, Radboud University Medical Center, 6229 HX Maastricht, The Netherlands
| | - Henricus Dirk P M Kunst
- Dutch Academic Alliance Skull Base Pathology, Maastricht University Medical Center+, Radboud University Medical Center, 6229 HX Maastricht, The Netherlands
- Department of Otorhinolaryngology, Head & Neck Surgery, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands
- Department of Otorhinolaryngology, Head & Neck Surgery, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
| | - Inge Compter
- Dutch Academic Alliance Skull Base Pathology, Maastricht University Medical Center+, Radboud University Medical Center, 6229 HX Maastricht, The Netherlands
- Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Center+, 6229 ET Maastricht, The Netherlands
| | - Jasper Van Aalst
- Department of Neurosurgery, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands
- Dutch Academic Alliance Skull Base Pathology, Maastricht University Medical Center+, Radboud University Medical Center, 6229 HX Maastricht, The Netherlands
| | - Daniëlle B P Eekers
- Dutch Academic Alliance Skull Base Pathology, Maastricht University Medical Center+, Radboud University Medical Center, 6229 HX Maastricht, The Netherlands
- Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Center+, 6229 ET Maastricht, The Netherlands
| | - Yasin Temel
- Department of Neurosurgery, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands
- Dutch Academic Alliance Skull Base Pathology, Maastricht University Medical Center+, Radboud University Medical Center, 6229 HX Maastricht, The Netherlands
| |
Collapse
|
12
|
Park JS, Kim DH, Kim SW, Kim SW, Ahn S, Basurrah MA, Jeun SS. Sinonasal Outcomes of the Combined Transseptal/Transnasal Approach with Unilateral Nasoseptal Rescue Flap in Endoscopic Endonasal Transsphenoidal Surgery: A Propensity Score Matching Analysis. J Neurol Surg B Skull Base 2024; 85:21-27. [PMID: 38327514 PMCID: PMC10849868 DOI: 10.1055/a-1946-0240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Accepted: 09/13/2022] [Indexed: 10/14/2022] Open
Abstract
Objectives The authors applied surgical techniques acquired during the use of endoscopic combined transseptal/transnasal approach to reduce approach-related morbidity and improve sinonasal outcomes. Study Design This is a retrospective cohort study of a prospectively collected database. Setting The study setting involves a tertiary referral center. Participants A total of 86 patients who underwent endoscopic endonasal transsphenoidal surgery for newly diagnosed pituitary adenomas from April 2018 to March 2021 were included. Patients treated via the combined transseptal/transnasal approach served as the study group ( n = 18); those treated via the bilateral transnasal approach comprised the control group ( n = 68). From the control group, propensity score matching (PSM) analysis was further performed to account for potential confounders and selection bias. Main Outcome Measures Paired analysis was performed for pre- and 6-month-postoperative time points in study group, control group, and PSM control group. Olfactory function was evaluated by Connecticut Chemosensory Clinical Research Center (CCCRC) test, Cross-Cultural Smell Identification Test (CCSIT), and sinonasal outcomes were assessed by Sino-Nasal Outcome Test-22 (SNOT-22). Results In the study group, CCCRC ( p = 0.517) and CCSIT ( p = 0.497) did not show any significant difference before and after surgery. There was some improvement in the symptom score of SNOT-22, but it was not statistically significant ( p = 0.115). In the control group adjusted with PSM, a significant decrease in olfaction ( p = 0.047) was observed using CCCRC. The CCSIT score was also decreased but not significant ( p = 0.163). Also, there was no difference in the improvement of SNOT-22 ( p = 0.781). Conclusion Our new surgical method preserves olfactory function without compromising surgical outcomes.
Collapse
Affiliation(s)
- Jae-Sung Park
- Department of Neurosurgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - Do Hyun Kim
- Department of Otolaryngology-Head and Neck Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - Sung Won Kim
- Department of Otolaryngology-Head and Neck Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - Soo Whan Kim
- Department of Otolaryngology-Head and Neck Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - Stephen Ahn
- Department of Neurosurgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | | | - Sin-Soo Jeun
- Department of Neurosurgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| |
Collapse
|
13
|
Senger S, Radtke K, Oertel J. Full Endoscopic Transcranial Resection of Meningiomas. Adv Tech Stand Neurosurg 2024; 52:129-138. [PMID: 39017791 DOI: 10.1007/978-3-031-61925-0_10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/18/2024]
Abstract
OBJECTIVE Tumors of the skull base can be accessed through different routes. Recent advantages in minimally invasive techniques have shown that very different routes can be applied for optimal tumor resection depending on the technical equipment, the surgeon's preference, and the individual anatomy of the pathology. Here, the authors present their technique for pure endoscopic transcranial tumor resection in meningiomas. METHODS Out of the cases of the Department of Neurosurgery, Homburg Saar Germany of the last 10 years, all endoscopic procedures for meningiomas were analyzed. Particular attention was given to evaluating the peculiarities of those meningiomas that were treated purely endoscopically. RESULTS While the endoscope was used in a large number of skull base meningiomas in endonasal approaches or for endoscopic inspection in transcranial skull base surgery, only a small number of meningiomas was selected for a purely endoscopically performed resection. The characteristics of these cases were rather a small lesion, straight access, and a keyhole position of the craniotomy. A complete resection of the tumor was achieved in all cases. Conversion to the microscope was not necessary in any case. There were no technical issues or complications associated with a fully endoscopic resection. DISCUSSION The endoscope is a valuable tool for visualization in meningioma surgery. In most cases, it is applied for an endonasal route or for endoscopic inspection in transcranial microsurgical cases. However, small to medium-sized meningiomas that can be accessed through the keyhole approach are good candidates for pure endoscopic resection. Because of the very high magnification and the minimally invasive nature of this approach, it should be considered more frequently in suitable lesions.
Collapse
Affiliation(s)
- Sebastian Senger
- Klinik für Neurochirurgie, Universitätsklinikum des Saarlandes und Fakultät für Medizin, Universität des Saarlandes, Homburg Saar, Germany
| | - Karen Radtke
- Klinik für Neurochirurgie, Universitätsklinikum des Saarlandes und Fakultät für Medizin, Universität des Saarlandes, Homburg Saar, Germany
| | - Joachim Oertel
- Klinik für Neurochirurgie, Universitätsklinikum des Saarlandes und Fakultät für Medizin, Universität des Saarlandes, Homburg Saar, Germany.
| |
Collapse
|
14
|
Uda T. Neuroimaging of Brain Tumor Surgery and Epilepsy. Brain Sci 2023; 13:1701. [PMID: 38137149 PMCID: PMC10742002 DOI: 10.3390/brainsci13121701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2023] [Accepted: 12/06/2023] [Indexed: 12/24/2023] Open
Abstract
To make the best clinical judgements, surgeons need to integrate information acquired via multimodal imaging [...].
Collapse
Affiliation(s)
- Takehiro Uda
- Department of Neurosurgery, Osaka Metropolitan University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka City 545-8585, Osaka, Japan
| |
Collapse
|
15
|
Tosoni A, Di Nunno V, Gatto L, Corradi G, Bartolini S, Ranieri L, Franceschi E. Olfactory neuroblastoma: diagnosis, management, and current treatment options. Front Oncol 2023; 13:1242453. [PMID: 37909011 PMCID: PMC10613987 DOI: 10.3389/fonc.2023.1242453] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2023] [Accepted: 09/25/2023] [Indexed: 11/02/2023] Open
Abstract
Olfactory neuroblastoma (ONB) is a rare neoplasm originating from the olfactory neuroepithelium representing 3-6% of tumors of the sinonasal tract. ONB require multi-disciplinary care. Historically, the gold standard surgical procedure for ONB has been open craniofacial resection. In the last years, endoscopic endonasal approaches have been largely introduced with lower complication rates, shorter hospital stay, and similar clinical outcome. Radiotherapy plays an important role in the management of ONB, however there are not generally accepted recommendations for its application. Although there is agreement that multimodal therapy is needed, the optimal use of chemotherapy is still unknown. The rarity of the disease, makes difficult to draw definitive conclusions about the role of systemic treatment in induction and concomitant setting.
Collapse
Affiliation(s)
- Alicia Tosoni
- Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
| | - Vincenzo Di Nunno
- Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
| | - Lidia Gatto
- Department of Oncology, Azienda Unità Sanitaria Locale (AUSL) Bologna, Bologna, Italy
| | - Giacomo Corradi
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
| | - Stefania Bartolini
- Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
| | - Lucia Ranieri
- Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
| | - Enrico Franceschi
- Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
| |
Collapse
|
16
|
Zhang G, Wang J, Wang P, Wu N. Endoscopic Ipsilateral Interhemispheric Approach for Middle-Third Falcine Meningioma: A Case Report and Literature Review. Brain Sci 2023; 13:1085. [PMID: 37509015 PMCID: PMC10377495 DOI: 10.3390/brainsci13071085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2023] [Revised: 07/13/2023] [Accepted: 07/14/2023] [Indexed: 07/30/2023] Open
Abstract
Middle-third falcine meningiomas (FMs) are usually hidden deep under the eloquent cortex and abundant bridging veins, which represent the main hindrances to surgical access. The endoscopic approach has the advantages of wide visualization and free visual axis without areas of visual blindness, which allows for the resection of FMs with good visualization in a narrow space, especially in deep operations. Here, we report a case of a middle-third FM treated using the endoscopic ipsilateral interhemispheric approach. A 55-year-old female who had suffered a headache for 6 months without other remarkable symptoms was diagnosed with middle-third FM combined with imaging evaluation. According to the imaging performance and anatomical features, we scheduled the endoscopic ipsilateral interhemispheric approach to access and remove the tumor. Consequently, gross total tumor resection was achieved without surgery-related complications. After the surgery, the patient had an uneventful recovery and was discharged with no neurological deficit. During the 24-month follow-up, the patient's condition remained favorable, with no tumor recurrence. In our opinion, the endoscopic ipsilateral interhemispheric approach is a feasible surgical strategy for FMs, which deserves further exploration as a treatment option.
Collapse
Affiliation(s)
- Gang Zhang
- Department of Neurosurgery, Chongqing General Hospital, Chongqing 401147, China
- Graduate Institute, Chongqing Medical University, Chongqing 400016, China
| | - Junwei Wang
- Department of Neurosurgery, Chongqing General Hospital, Chongqing 401147, China
| | - Pan Wang
- Department of Neurosurgery, Chongqing General Hospital, Chongqing 401147, China
| | - Nan Wu
- Department of Neurosurgery, Chongqing General Hospital, Chongqing 401147, China
| |
Collapse
|
17
|
Truong TT, Pham BT, Nguyen HV, Nguyen AM. Endoscopic endonasal surgery for resection of anterior skull base meningiomas: A single-center prospective study in Vietnam. INTERDISCIPLINARY NEUROSURGERY 2023. [DOI: 10.1016/j.inat.2022.101671] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
18
|
Samarage HM, Kim WJ, Zarrin DA, Goel K, Kim W, Bergsneider M, Wang MB, Suh JD, Lee JT, Colby GP, Johnson JN, Peacock WJ, Wang AC. Endoscope-Assisted Pedicled Maxillary Artery to Middle Cerebral Artery Bypass: An Anatomic Feasibility Study. Oper Neurosurg (Hagerstown) 2023; 24:209-220. [PMID: 36637306 DOI: 10.1227/ons.0000000000000492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2022] [Accepted: 08/31/2022] [Indexed: 01/14/2023] Open
Abstract
BACKGROUND Extracranial to intracranial bypass is used to augment and/or replace the intracranial circulation for various pathologies. The superficial temporal artery is the mainstay donor for pedicled bypasses to the anterior circulation but can be limited by its variable size, low native flow rates, and potential scalp complications. Interposition grafts such as the radial artery or greater saphenous vein are alternatives but are sometimes limited by size mismatch, length needed to reach the extracranial circulation, and loss of inherent vascular elasticity. Interposition grafts between the maxillary artery (IMA) and middle cerebral artery (MCA) address these limitations. OBJECTIVE To explore the feasibility of harvesting the IMA through an endoscopic transnasal, transmaxillary approach to perform a direct IMA to MCA bypass. METHODS Combined transcranial and endoscopic endonasal dissections were performed in embalmed human cadavers to harvest the IMAs for intracranial transposition and direct anastomosis to the MCA. Donor and recipient vessel calibers were measured and recorded. RESULTS A total of 8 procedures were performed using the largest and distal-most branches of the IMA (the sphenopalatine branch and the descending palatine branch) as pedicled conduits to second division of middle cerebral artery (M2) recipients. The mean diameter of the IMA donors was 1.89 mm (SD ± 0.42 mm), and the mean diameter of the recipient M2 vessels was 1.90 mm (SD ± 0.46 mm). CONCLUSION Endoscopic harvest of the IMA using a transnasal, transmaxillary approach is a technically feasible option offering an excellent size match to the M2 divisions of the MCA and the advantages of a relatively short, pedicled donor vessel.
Collapse
Affiliation(s)
- Hasitha Milan Samarage
- Department of Neurosurgery, University of California Los Angeles, Los Angeles, California, USA
| | - Wi Jin Kim
- Department of Neurosurgery, University of California Los Angeles, Los Angeles, California, USA
| | - David A Zarrin
- David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA
| | - Keshav Goel
- David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA
| | - Won Kim
- Department of Neurosurgery, University of California Los Angeles, Los Angeles, California, USA.,David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.,Department of Radiation Oncology, University of California Los Angeles, Los Angeles, California, USA
| | - Marvin Bergsneider
- Department of Neurosurgery, University of California Los Angeles, Los Angeles, California, USA.,David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.,Department of Head and Neck Surgery, University of California Los Angeles, Los Angeles, California, USA
| | - Marilene B Wang
- Department of Neurosurgery, University of California Los Angeles, Los Angeles, California, USA.,David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.,Department of Head and Neck Surgery, University of California Los Angeles, Los Angeles, California, USA
| | - Jeffrey D Suh
- David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.,Department of Head and Neck Surgery, University of California Los Angeles, Los Angeles, California, USA
| | - Jivianne T Lee
- David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.,Department of Head and Neck Surgery, University of California Los Angeles, Los Angeles, California, USA
| | - Geoffrey P Colby
- Department of Neurosurgery, University of California Los Angeles, Los Angeles, California, USA.,David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.,Department of Radiology, University of California Los Angeles, Los Angeles, California, USA
| | - Jeremiah N Johnson
- Department of Neurosurgery, University of California Los Angeles, Los Angeles, California, USA
| | - Warwick J Peacock
- Department of Neurosurgery, University of California Los Angeles, Los Angeles, California, USA.,David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.,Department of Surgery, University of California Los Angeles, California, USA
| | - Anthony C Wang
- Department of Neurosurgery, University of California Los Angeles, Los Angeles, California, USA.,David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA
| |
Collapse
|
19
|
Castle-Kirszbaum M, Wang YY, King J, Kam J, Goldschlager T. The HACKD Score-Predicting Extent of Resection of Pituitary Macroadenomas Through an Endoscopic Endonasal Transsphenoidal Approach. Oper Neurosurg (Hagerstown) 2023; 24:154-161. [PMID: 36354325 DOI: 10.1227/ons.0000000000000488] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Accepted: 08/26/2022] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Predicting extent of resection before pituitary surgery is imperative for operative planning and patient counseling. In the era of endoscopic endonasal transsphenoidal surgery (EEA), a specific, reliable tool for predicting resection of macroadenomas would have widespread applications. OBJECTIVE To identify factors that predict resection of pituitary macroadenomas through the EEA. METHODS A prospectively maintained, multicenter database of 277 consecutive macroadenomas resected through the EEA was analyzed. Multivariate logistic regression identified predictors of gross total resection (GTR). A simple scoring system, the Hardy, Age, Clival, Knosp, Depth (HACKD) Score, was developed and tested. RESULTS GTR was achieved in 82.3% (228/277) of cases. Older than 50 years (odds ratio [OR] 2.96, P = .01), clival extension (OR 5.87, P < .01), Hardy grade C or D suprasellar extension (OR 3.91, P = .01), Knosp grade 3 or 4 cavernous sinus invasion (OR 7.62, P < .01), and tumor depth >20 mm (OR 5.14, P < .01) were all associated with subtotal resection. The HACKD score, awarding 1 point each for Hardy grade C or D, and older than 50 years, and 2 points each for clival extension, Knosp grades 3 or 4, and tumor depth >20 mm, demonstrated excellent discriminative ability (AUROC 0.887, 95% CI: 0.839-0.934). The rate of GTR progressively decreased with a higher HACKD score. Rates of GTR were 95.8% (182/190) for low (HACKD ≤2), 59.5% (44/74) for moderate (HACKD 3-5), and 15.4% (2/13) for high (HACKD 6+) HACKD scores. CONCLUSION The HACKD score is a simple and accurate tool based on the largest study analyzing predictors of GTR in pituitary macroadenomas operated through the EEA.
Collapse
Affiliation(s)
- Mendel Castle-Kirszbaum
- Department of Neurosurgery, Monash Health, Melbourne, Australia.,Department of Surgery, Monash University, Melbourne, Australia
| | - Yi Yuen Wang
- Department of Neurosurgery, St Vincent's Health, Melbourne, Australia
| | - James King
- Department of Neurosurgery, Royal Melbourne Hospital, Melbourne, Australia
| | - Jeremy Kam
- Department of Neurosurgery, Monash Health, Melbourne, Australia.,Department of Neurosurgery, Royal Melbourne Hospital, Melbourne, Australia
| | - Tony Goldschlager
- Department of Neurosurgery, Monash Health, Melbourne, Australia.,Department of Surgery, Monash University, Melbourne, Australia
| |
Collapse
|
20
|
Parasher AK, Lerner DK, Miranda SP, Douglas JE, Glicksman JT, Alexander T, Lin T, Ebesutani D, Kohanski M, Lee JY, Storm PB, O'Malley BW, Yoshor D, Palmer JN, Grady MS, Adappa ND. In-Hospital Costs for Open versus Endoscopic Endonasal Approach for Craniopharyngioma Resection. Laryngoscope 2023; 133:83-87. [PMID: 35929639 DOI: 10.1002/lary.30313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2022] [Revised: 06/02/2022] [Accepted: 07/07/2022] [Indexed: 02/02/2023]
Abstract
OBJECTIVE To determine the in-hospital cost implications of an expanded endoscopic endonasal approach (EEEA) for craniopharyngioma resection relative to the traditional open transcranial approach. METHODS All craniopharyngioma surgeries performed at a single institution over a period from January 1st 2001 to October 31th 2017 were evaluated. The electronic medical record was reviewed for patient factors, tumor characteristics, and cost variables associated with each hospital stay and univariate regression analysis was performed using R software. RESULTS Thirty-six patients met study criteria, including 22 undergoing an open approach and 14 undergoing an EEEA. There was a significantly longer average length of stay among patients undergoing open resection (21.5 vs. 10.6 days, p = 0.024). The average total in-hospital cost of a patient undergoing an EEEA was $58979.3 compared to $89142.3 for an open approach (p = 0.127). On univariate regression analysis, the total in-hospital cost for a patient undergoing an open approach relative to an EEEA was $30163.0 (p = 0.127). The open approach was exclusively performed from study onset until April 2010 (16 patients). From April 2010 to August 2013, 6 open approaches and 5 EEEA were performed. The EEEA has been exclusively performed from August 2013 until the conclusion of our study period (9 patients). CONCLUSIONS There has been a shift toward surgical resection of craniopharyngioma via an EEEA approach for amenable tumors. Our study demonstrates that the EEEA has become the preferred surgical approach at our institution, and shows that the EEEA is associated with shorter postoperative length of stay and lower total in-hospital cost. Laryngoscope, 133:83-87, 2023.
Collapse
Affiliation(s)
- Arjun K Parasher
- Department of Otolaryngology: Head and Neck Surgery, University of South Florida, Tampa, Florida, USA.,College of Public Health, University of South Florida, Tampa, Florida, USA
| | - David K Lerner
- Department of Otolaryngology: Head and Neck Surgery, Icahn School of Mount Sinai, New York City, New York, USA
| | - Stephen P Miranda
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Jennifer E Douglas
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Jordan T Glicksman
- Department of Otolaryngology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.,Department of Otolaryngology, New England Ear Nose and Throat, Newton, Massachusetts, USA
| | - Tyler Alexander
- Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Theodore Lin
- Department of Otolaryngology-Head and Neck Surgery, Temple University, Philadelphia, Pennsylvania, USA
| | - Darren Ebesutani
- Office of Clinical Research, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Michael Kohanski
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - John Yk Lee
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Phillip B Storm
- Division of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
| | - Bert W O'Malley
- Department of Otolaryngology-Head and Neck Surgery, University of Maryland Medical Center, Baltimore, Maryland, USA
| | - Daniel Yoshor
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - James N Palmer
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - M Sean Grady
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Nithin D Adappa
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| |
Collapse
|
21
|
Parasher AK, Lerner DK, Miranda SP, Douglas JE, Glicksman JT, Alexander T, Lin T, Ebesutani D, Kohanski M, Lee JY, Storm PB, O’Malley BW, Yoshor D, Palmer JN, Grady MS, Adappa ND. In-Hospital Cost Comparison for Open Versus Endoscopic Endonasal Approach for Meningioma Resection. Am J Rhinol Allergy 2022; 37:324-329. [PMID: 36529537 DOI: 10.1177/19458924221145893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Objective To determine the in-hospital cost implications of an endoscopic expanded endonasal approach (EEEA) for meningioma resection relative to the open transcranial approach. Methods All anterior skull base meningioma surgeries performed over a period from January 1st, 2015 to October 31th, 2017 were evaluated. The electronic medical record was reviewed for patient factors, tumor characteristics, and cost variables associated with each hospital stay and univariate analysis was performed using R software. All cost data were converted into August 2021-equivalent dollar amounts using the United States Bureau of Labor Statistics consumer price index. Results Thirty-five patients met study criteria, including 27 patients undergoing an open transcranial approach and 8 undergoing an EEEA. Average length of stay for patients undergoing an open approach was 9.3 days compared to 5.6 within the EEEA group ( P = .126). The average total in-hospital cost of patient undergoing an EEEA was $35417.1 compared to $46406.9 among patients undergoing an open transcranial approach ( P = .168). On univariate analysis, the cost of an open transcranial approach relative to the EEEA was $10989.8 ( P = .411). Conclusions The open transcranial approach remained the dominant surgical approach to anterior skull base meningiomas over our study time period. However, despite limited patient numbers the EEEA was associated with decreased total in-hospital costs.
Collapse
Affiliation(s)
- Arjun K. Parasher
- Department of Otolaryngology-Head and Neck Surgery, University of South Florida, Tampa, Florida
- College of Public Health, University of South Florida, Tampa, Florida
| | - David K. Lerner
- Department of Otolaryngology: Head and Neck Surgery, Icahn School of Mount Sinai, NYC, New York
| | - Stephen P. Miranda
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Jennifer E. Douglas
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Jordan T. Glicksman
- Department of Otolaryngology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
- New England Ear Nose and Throat, Newton, Massachusetts
| | - Tyler Alexander
- Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania
| | - Theodore Lin
- Department of Otolaryngology-Head and Neck Surgery, Temple University, Philadelphia, Pennsylvania
| | - Darren Ebesutani
- Office of Clinical Research, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Michael Kohanski
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania
| | - John Y.K. Lee
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Phillip B. Storm
- Division of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
| | - Bert W. O’Malley
- Department of Otolaryngology-Head and Neck Surgery, University of Maryland Medical Center, Baltimore, Maryland
| | - Daniel Yoshor
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania
| | - James N. Palmer
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania
| | - M. Sean Grady
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Nithin D. Adappa
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania
| |
Collapse
|
22
|
Strickland BA, Wedemeyer M, Ruzevick J, Micko A, Shahrestani S, Daneshmand S, Shiroishi MS, Hwang DH, Attenello F, Chen T, Zada G. 5-Aminolevulinic acid-enhanced fluorescence-guided treatment of high-grade glioma using angled endoscopic blue light visualization: technical case series with preliminary follow-up. J Neurosurg 2022; 137:1378-1386. [PMID: 35303704 DOI: 10.3171/2022.1.jns212562] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2021] [Accepted: 01/25/2022] [Indexed: 11/06/2022]
Abstract
OBJECTIVE 5-Aminolevulinic acid (5-ALA)-enhanced fluorescence-guided resection of high-grade glioma (HGG) using microscopic blue light visualization offers the ability to improve extent of resection (EOR); however, few descriptions of HGG resection performed using endoscopic blue light visualization are currently available. In this report, the authors sought to describe their surgical experience and patient outcomes of 5-ALA-enhanced fluorescence-guided resection of HGG using primary or adjunctive endoscopic blue light visualization. METHODS The authors performed a retrospective review of prospectively collected data from 30 consecutive patients who underwent 5-ALA-enhanced fluorescence-guided biopsy or resection of newly diagnosed HGG was performed. Patient demographic data, tumor characteristics, surgical technique, EOR, tumor fluorescence patterns, and progression-free survival were recorded. RESULTS In total, 30 newly diagnosed HGG patients were included for analysis. The endoscope was utilized for direct 5-ALA-guided port-based biopsy (n = 9), microscopic to endoscopic (M2E; n = 18) resection, or exoscopic to endoscopic (E2E; n = 3) resection. All endoscopic biopsies of fluorescent tissue were diagnostic. 5-ALA-enhanced tumor fluorescence was visible in all glioblastoma cases, but only in 50% of anaplastic astrocytoma cases and no anaplastic oligodendroglioma cases. Gross-total resection (GTR) was achieved in 10 patients in whom complete resection was considered safe, with 11 patients undergoing subtotal resection. In all cases, endoscopic fluorescence was more avid than microscopic fluorescence. The endoscope offered the ability to diagnose and resect additional tumor not visualized by the microscope in 83.3% (n = 10/12) of glioblastoma cases, driven by angled lenses and increased fluorescence facilitated by light source delivery within the cavity. Mean volumetric EOR was 90.7% in all resection patients and 98.8% in patients undergoing planned GTR. No complications were attributable to 5-ALA or blue light endoscopy. CONCLUSIONS The blue light endoscope is a viable primary or adjunctive visualization platform for optimization of 5-ALA-enhanced HGG fluorescence. Implementation of the blue light endoscope to guide resection of HGG glioma is feasible and ergonomically favorable, with a potential advantage of enabling increased detection of tumor fluorescence in deep surgical cavities compared to the microscope.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Mark S Shiroishi
- 3Radiology, USC/Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California
| | - Darryl H Hwang
- 3Radiology, USC/Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California
| | | | | | | |
Collapse
|
23
|
Xin G, Liu Y, Xiong Y, Xie S, Luo H, Xiao L, Wu X, Hong T, Tang B. The use of three-dimensional endoscope in transnasal skull base surgery: A single-center experience from China. Front Surg 2022; 9:996290. [PMID: 36211263 PMCID: PMC9537740 DOI: 10.3389/fsurg.2022.996290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2022] [Accepted: 09/05/2022] [Indexed: 12/05/2022] Open
Abstract
Objective The development of skull base surgery in the past decade has been influenced by advances in visualization techniques; recently, due to such improvements, 3D endoscopes have been widely used. Herein, we address its effect for transnasal endoscopic skull base surgery. Methods A total of 63 patients who under endoscopic endonasal surgery (EES) with 3-D endoscope were retrospectively reviewed, including pituitary adenomas, craniopharyngiomas, meningiomas, Rathke’s cleft cysts, and chordomas. According to different lesions, transsellar approach (24 cases), transsphenoidal–transtuberculum approach (14 cases), transclival approach (6 cases), and transpterygoid approach (19 cases) were selected. Results Total removal of tumors was achieved in 56 patients (88.9%) and subtotal removal in 7 cases (11.1%). Complications included diabetes insipidus in seven patients (11.1%), cerebrospinal fluid (CSF) leakage in two patients (3.2%), major vascular injury occurred in one patient (1.6%), cranial nerve injury in nine patients (14.3%), and meningitis in two patients (3.2%). There was no mortality in the series. All patients recovered and were back to normal daily life, and no tumor recurrence or delayed CSF leakage was detected during the follow-up (2–13 months, mean 7.59 months). Conclusions Via 3D EES, it improved depth perception and preserved important neurovascular tissue when tumors were removed, which is important for improving the operative prognosis.
Collapse
Affiliation(s)
- Guo Xin
- Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - Yajing Liu
- Operating Theater, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - Yicheng Xiong
- Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - Shenhao Xie
- Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - Hai Luo
- Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - Liming Xiao
- Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - Xiao Wu
- Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - Tao Hong
- Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - Bin Tang
- Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, China
- Correspondence: Bin Tang
| |
Collapse
|
24
|
Palmieri D, Champagne PO, Valappil B, McDowell MM, Gardner PA, Snyderman CH. Risk Factors in a Pediatric Population for Postoperative Intracranial Infection Following Endoscopic Endonasal Skull Base Surgery and the Role of Antibiotic Prophylaxis. Am J Rhinol Allergy 2022; 37:13-18. [PMID: 36050937 DOI: 10.1177/19458924221123113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND Endoscopic endonasal skull base surgery (EESBS) is performed through a non-sterile corridor. Intracranial infection rates in a pediatric population have not been extensively studied and the exact effect of antibiotic prophylaxis on rates of infection after EESBS in pediatric patients remains unclear. OBJECTIVE The purpose of our study is to investigate risk factors for postoperative intracranial infection during EESBS in a pediatric population and help elucidate the role of antibiotic prophylaxis. METHODS We conducted a retrospective chart review of 99 consecutive patients under the age of 18 who underwent EESBS at our institution from 2013 to 2021. Centers for Disease Control and Prevention/National Healthcare Safety Network criteria for diagnosis of meningitis were used to identify postoperative intracranial infections. RESULTS The average age was 12.3 years (range 1.6-18) with 66 male patients and 33 female patients. 49 patients had an intraoperative cerebrospinal fluid (CSF) leak, of which 4 had a postoperative CSF leak. We identified 3 postoperative intracranial infections (3%), which were all meningitis cases. The infection rate was 6% (3/49) among those with intraoperative CSF leaks. All patients with meningitis had a postoperative CSF leak. All infections were transclival approaches (2 chordoma and 1 neurenteric cyst). CONCLUSION This investigation represents one of the largest pediatric endoscopic skull base surgery cohorts. EESBS is safe to perform in pediatric populations, but transclival approaches and postoperative CSF leaks are risk factors for postoperative meningitis.
Collapse
Affiliation(s)
- Daniel Palmieri
- 12317University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| | - Pierre-Olivier Champagne
- Department of Neurological Surgery, 12317University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| | - Benita Valappil
- Department of Otolaryngology, 12317University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| | - Michael M McDowell
- Department of Neurological Surgery, 12317University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| | - Paul A Gardner
- Department of Neurological Surgery, 12317University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| | - Carl H Snyderman
- Department of Otolaryngology, 12317University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| |
Collapse
|
25
|
Henderson F, Youngerman BE, Niogi SN, Alexander T, Tabaee A, Kacker A, Anand VK, Schwartz TH. Endonasal transsphenoidal surgery for planum sphenoidale versus tuberculum sellae meningiomas. J Neurosurg 2022; 138:1338-1346. [PMID: 36461840 DOI: 10.3171/2022.8.jns22632] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2022] [Accepted: 08/09/2022] [Indexed: 11/06/2022]
Abstract
OBJECTIVE
The aim of this study was to determine if the distinction between planum sphenoidale (PS) and tuberculum sellae (TS) meningiomas is clinically meaningful and impacts the results of the endoscopic endonasal approach (EEA).
METHODS
A consecutive series of patients who were 18 years of age or older and underwent EEA for newly diagnosed grade I PS meningiomas (PSMs) and TS meningiomas (TSMs) between October 2007 and May 2021 were included. The PS and TS were distinguished by drawing a line passing through the center of the TS and perpendicular to the PS on postcontrast T1-weighted MRI. Probabilistic heatmaps were created to display the actual distribution of tumor volumes. Tumor volume, extent of resection (EOR), visual outcome, and complications were assessed.
RESULTS
The 47 tumors were distributed in a smooth continuum. Using an arbitrary definition, 24 (51%) were PSMs and 23 (49%) were TSMs. The mean volume of PSMs was 5.6 cm3 compared with 4.5 cm3 for TSMs. Canal invasion was present in 87.5% of PSMs and 52% of TSMs. GTR was achieved in 38 (84%) of 45 cases in which it was the goal, slightly less frequently for PSMs (78%) compared with TSMs (91%), although the difference was not significant. Th mean EOR was 99% ± 2% for PSMs and 98% ± 11% for TSMs. Neither the suprasellar notch angle nor the percentage of tumor above the PS impacted the rate of GTR. After a median follow-up of 28.5 months (range 0.1–131 months), there were 2 (5%) recurrences after GTR (n = 38) both of which occurred in patients with PSMs. Forty-two (89%) patients presented with preoperative impaired vision. Postoperative vision was stable or improved in 96% of patients with PSMs and 91% of patients with TSMs. CSF leakage occurred in 4 (16.6%) patients with a PSM, which resolved with only lumbar drainage, and in 1 (4.3%) patient with a TSM, which required reoperation.
CONCLUSIONS
PSM and TSMs arise in a smooth distribution, making the distinction arbitrary. Those classified as PSMs were larger and more likely to invade the optic canals. Surgical outcome for both locations was similar, slightly favoring TSMs. The arbitrary distinction between PSMs and TSMs is less useful at predicting outcome than the lateral extent of the tumor, regardless of the site of origin.
Collapse
Affiliation(s)
| | - Brett E. Youngerman
- Department of Neurosurgery, Columbia University Medicine, NewYork-Presbyterian Hospital, New York, New York; and
| | | | - Tyler Alexander
- Thomas Jefferson University, School of Medicine, Philadelphia, Pennsylvania
| | - Abtin Tabaee
- Otolaryngology, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York
| | - Ashutosh Kacker
- Otolaryngology, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York
| | - Vijay K. Anand
- Otolaryngology, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York
| | | |
Collapse
|
26
|
Shao D, Li Y, Zhang B, Wu J, Xie S, Zheng X, Jiang Z. Endoscope-assisted microneurosurgery for intracranial aneurysms: A systematic review and meta-analysis. J Clin Neurosci 2022; 103:62-71. [PMID: 35816766 DOI: 10.1016/j.jocn.2022.06.029] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2022] [Revised: 06/29/2022] [Accepted: 06/30/2022] [Indexed: 11/16/2022]
Abstract
BACKGROUND In the surgical approach to treat deep-seated intracranial lesions, endoscopes can be used to assist microsurgical operations and improve outcomes. This technique is often called endoscope-assisted microneurosurgery (EAM). This systematic review and meta-analysis aimed to evaluate the feasibility, safety, and effectiveness of EAM. METHODS We performed a meta-analysis of relevant articles identified using PubMed, Embase, and the Cochrane Central Register to assess the efficacy of EAM according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria. Primary outcomes were repositioning of the definitive clip, better surgical field, the overall and endoscope-related complication rates, mortality, and the rate of follow up. RESULTS A total of 10 studies of 1,432 patients with 1,717 aneurysms treated with EAM were included. EAM led to repositioning of the definitive clip in 13% (95% CI, 9%-17%; I2 = 72.61%; p < 0.001); 77% of aneurysms treated with endoscopically assisted vision and information had a better outcome than that with standard surgery (95% CI, 52%-95%; I2 = 97.63%; p < 0.001). There was an overall complication rate of 6% (95% CI, 1%-13%; I2 = 91.39%; p < 0.001). The incidence of endoscope-related complications was 0% (95% CI, 0%-1%; I2 = 64%; p < 0.001). The mortality was 0% (95% CI, 0-1%; I2 = 0.0%); and 94% of patients had an excellent to good recovery and good outcome (95% CI, 88%-98%; I2 = 88.42%; p < 0.001). CONCLUSIONS Our comprehensive study showed that EAM for intracranial aneurysms is feasible, the safety of the surgery is good, and the patients have a good prognosis, Therefore, we think EAM can be more widely adopted in the future.
Collapse
Affiliation(s)
- Dongqi Shao
- Department of Neurosurgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China
| | - Yu Li
- Department of Neurosurgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China
| | - Binbin Zhang
- Department of Neurosurgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China
| | - Junyong Wu
- Department of Neurosurgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China
| | - Shan Xie
- Department of Neurosurgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China
| | - Xialin Zheng
- Department of Neurosurgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China
| | - Zhiquan Jiang
- Department of Neurosurgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China.
| |
Collapse
|
27
|
Rao D, Stein R, Jenson M, Patel J, Fiester P. Imaging Review of the Endoscopic Operative Corridor for Clivus Lesions. Curr Probl Diagn Radiol 2022; 52:66-76. [DOI: 10.1067/j.cpradiol.2022.07.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2022] [Revised: 06/09/2022] [Accepted: 07/27/2022] [Indexed: 11/22/2022]
|
28
|
Lim J, Sung KS, Kim W, Yoo J, Jung IH, Choi S, Lim SH, Roh TH, Hong CK, Moon JH. Extended endoscopic transorbital approach with superior-lateral orbital rim osteotomy: cadaveric feasibility study and clinical implications (SevEN-007). J Neurosurg 2022; 137:18-31. [PMID: 34767525 DOI: 10.3171/2021.7.jns21996] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2021] [Accepted: 07/07/2021] [Indexed: 11/06/2022]
Abstract
OBJECTIVE The endoscopic transorbital approach (ETOA) has been developed, permitting a new surgical corridor. Due to the vertical limitation of the ETOA, some lesions of the anterior cranial fossa are difficult to access. The ETOA with superior-lateral orbital rim (SLOR) osteotomy can achieve surgical freedom of vertical as well as horizontal movement. The purpose of this study was to confirm the feasibility of the ETOA with SLOR osteotomy. METHODS Anatomical dissections were performed in 5 cadaveric heads with a neuroendoscope and neuronavigation system. ETOA with SLOR osteotomy was performed on one side of the head, and ETOA with lateral orbital rim (LOR) osteotomy was performed on the other side. After analysis of the results of the cadaveric study, the ETOA with SLOR osteotomy was applied in 6 clinical cases. RESULTS The horizontal and vertical movement range through ETOA with SLOR osteotomy (43.8° ± 7.49° and 36.1° ± 3.32°, respectively) was improved over ETOA with LOR osteotomy (31.8° ± 5.49° and 23.3° ± 1.34°, respectively) (p < 0.01). Surgical freedom through ETOA with SLOR osteotomy (6025.1 ± 220.1 mm3) was increased relative to ETOA with LOR osteotomy (4191.3 ± 57.2 mm3) (p < 0.01); these values are expressed as the mean ± SD. Access levels of ETOA with SLOR osteotomy were comfortable, including anterior skull base lesion and superior orbital area. The view range of the endoscope for anterior skull base lesions was increased through ETOA with SLOR osteotomy. After SLOR osteotomy, the space for moving surgical instruments and the endoscope was widened. Anterior clinoidectomy could be achieved successfully using ETOA with SLOR osteotomy. The authors performed ETOA with SLOR osteotomy in 6 cases of brain tumor. In all 6 cases, complete removal of the tumor was successfully accomplished. In the 3 cases of anterior clinoidal meningioma, anterior clinoidectomy was performed easily and safely, and manipulation of the extended dural margin and origin dura mater was possible. There was no complication related to this approach. CONCLUSIONS The authors evaluated the clinical feasibility of ETOA with SLOR osteotomy based on a cadaveric study. ETOA with SLOR osteotomy could be applied to more diverse disease groups that do not permit conventional ETOA or to cases in which surgical application is challenging. ETOA with SLOR osteotomy might serve as an opportunity to broaden the indication for the ETOA.
Collapse
Affiliation(s)
- Jaejoon Lim
- 1Department of Neurosurgery, Bundang CHA Medical Center, CHA University College of Medicine, Seongnam
| | - Kyoung Su Sung
- 2Department of Neurosurgery, Dong-A University Hospital, Dong-A University College of Medicine, Busan
| | - Woohyun Kim
- 3Department of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul
| | - Jihwan Yoo
- 4Department of Neurosurgery, Brain Tumor Center, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul
| | - In-Ho Jung
- 3Department of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul
| | - Seonah Choi
- 3Department of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul
| | - Seung Hoon Lim
- 3Department of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul
| | - Tae Hoon Roh
- 5Department of Neurosurgery, Ajou University Hospital, Ajou University College of Medicine, Suwon; and
| | - Chang-Ki Hong
- 4Department of Neurosurgery, Brain Tumor Center, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul
- 6Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - Ju Hyung Moon
- 3Department of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul
| |
Collapse
|
29
|
Visualization of Resected Area in Endonasal Endoscopic Approach versus Transcranial Approach for Skull Base Meningiomas by Voxel-Based-Lesion Mapping. Brain Sci 2022; 12:brainsci12070875. [PMID: 35884682 PMCID: PMC9313245 DOI: 10.3390/brainsci12070875] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2022] [Revised: 06/22/2022] [Accepted: 06/28/2022] [Indexed: 11/17/2022] Open
Abstract
Background: We aimed to evaluate the resected area of endonasal endoscopic approach (EEA) and transcranial approach (TCA) for skull base meningiomas (SBMs) using voxel-based-lesion mapping and visualized the appropriate tumor location in each approach. Methods: We retrospectively examined 182 patients with SBMs who underwent tumor resection in our hospital between 2014 and 2019. Pre- and post-operative SBMs were manually delineated on MRI to create the voxels-of-interest (VOIpre and VOIpost) and were registered onto the normalized brain (normalized VOIpre and normalized VOIpost). The resected map was created by subtracting normalized VOIpost from the normalized VOIpre divided by the number of cases. The resected maps of TCA and EEA were compared by subtracting them. Results: Twenty patients underwent EEA and 135 patients underwent TCA. The tumor resected map demonstrated that the resected area of EEA frequently accumulated on the central skull base, while that of TCA accumulated near the central skull base. The border of both approaches matched the circle that connects neural foramens at the skull base. Conclusions: The resected area of SBMs by EEA and TCA was well visualized by voxel-based-lesion mapping. The circle connecting the neural foramens was the border of EEA and TCA.
Collapse
|
30
|
Aljuboori Z, Nuru M, Sharma M, Andaluz N. Predictors of the Size and Surgical Freedom of the Trans-Cribriform and Trans-Clival Corridors, a Radiographic Analysis. Skull Base Surg 2022; 83:e24-e30. [DOI: 10.1055/s-0040-1722663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Accepted: 11/01/2020] [Indexed: 10/22/2022]
Abstract
Abstract
Introduction The transcribriform and transclival corridors are endoscopic endonasal approaches used to treat pathologies of the skull base. We present a predictive model that uses the clival length and ethmoidal width to predict the size and surgical freedom (SF) of these corridors.
Methods Adult facial computed tomography scans were reviewed. Exclusion criteria included patients <18 years of age or radiographic evidence of trauma, neoplasm, or congenital deformities of the skull base. The images were analyzed using OsiriX MD (Bernex, Switzerland). Patients' demographics, clival length, ethmoidal width, surface area, and others were collected. Linear regression was used to create prediction models for the size and SF of the transclival and transcribriform corridors.
Results A total of 103 patients were included with an average age of 44.9 years and 47% males. Females had a smaller clival surface area (8 vs. 9.2 cm2, p = 0.001). For transclival corridor, clival length correlated positively with SF in the sagittal plane (rho = 0.44, p < 0.05) and negatively with SF in the coronal plane (rho = − 0.2, p < 0.05). For transcribriform corridor, ethmoidal width correlated positively with SF in the coronal plane (rho = 0.74, p < 0.05), and negatively with SF in the sagittal plane (rho = − 0.2, p < 0.05).
Conclusion A significant variability of the bony anatomy of the anterior and central skull base was found. The use of clival length and ethmoidal width as part of preoperative surgical planning might help to overcome the anatomical variability which could affect the adequacy of surgical corridors.
Collapse
Affiliation(s)
- Zaid Aljuboori
- Department of Neurological Surgery, University of Louisville School of Medicine, Louisville, Kentucky, United States
| | - Mohammed Nuru
- Department of Neurological Surgery, University of Louisville School of Medicine, Louisville, Kentucky, United States
| | - Mayur Sharma
- Department of Neurological Surgery, University of Louisville School of Medicine, Louisville, Kentucky, United States
| | - Norberto Andaluz
- Department of Neurological Surgery, University of Louisville School of Medicine, Louisville, Kentucky, United States
| |
Collapse
|
31
|
Chondrosarcoma of the sella turcica: Case report and review. INTERDISCIPLINARY NEUROSURGERY 2022. [DOI: 10.1016/j.inat.2022.101523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|
32
|
Kalaiarasan K, Prathap L, Ayyadurai M, Subhashini P, Tamilselvi T, Avudaiappan T, Infant Raj I, Alemayehu Mamo S, Mezni A. Clinical Application of Augmented Reality in Computerized Skull Base Surgery. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE : ECAM 2022; 2022:1335820. [PMID: 35600956 PMCID: PMC9117015 DOI: 10.1155/2022/1335820] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/28/2022] [Accepted: 04/19/2022] [Indexed: 12/02/2022]
Abstract
Cranial base tactics comprise the regulation of tiny and complicated structures in the domains of otology, rhinology, neurosurgery, and maxillofacial medical procedure. Basic nerves and veins are in the nearness of these buildings. Increased the truth is a coming innovation that may reform the cerebral basis approach by supplying vital physical and navigational facts brought together in a solitary presentation. In any case, the awareness and acknowledgment of prospective results of expanding reality frameworks in the cerebral base region are really poor. This article targets examining the handiness of expanded reality frameworks in cranial foundation medical procedures and emphasizes the obstacles that present innovation encounters and their prospective adjustments. A specialized perspective on distinct strategies used being produced of an improved realty framework is furthermore offered. The newest item offers an expansion in interest in expanded reality frameworks that may motivate more secure and practical procedures. In any case, a couple of concerns have to be cared to before that can be for the vast part fused into normal practice.
Collapse
Affiliation(s)
- K. Kalaiarasan
- Department of Information Technology, M. Kumarasamy College of Engineering, Karur, India
| | - Lavanya Prathap
- Department of Anatomy, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu 600077, India
| | - M. Ayyadurai
- SG, Institute of ECE, Saveetha School of Engineering, SIMATS, Chennai, Tamil Nadu 600077, India
| | - P. Subhashini
- Department of Computer Science and Engineering, J.N.N Institute of Engineering, Kannigaipair, Tamil Nadu 601102, India
| | - T. Tamilselvi
- Department of Computer Science and Engineering, Panimalar Institute of Technology, Varadarajapuram, Tamil Nadu 600123, India
| | - T. Avudaiappan
- Computer Science and Engineering, K. Ramakrishnan College of Technology, Trichy 621112, India
| | - I. Infant Raj
- Department of Computer Science and Engineering, K. Ramakrishnan College of Engineering, Trichy, India
| | - Samson Alemayehu Mamo
- Department of Electrical and Computer Engineering, Faculty of Electrical and Biomedical Engineering, Institute of Technology, Hawassa University, Awasa, Ethiopia
| | - Amine Mezni
- Department of Chemistry, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia
| |
Collapse
|
33
|
Godil SS, Tosi U, Gerges M, Garton ALA, Dobri GA, Kacker A, Tabaee A, Anand VK, Schwartz TH. Long-term tumor control after endoscopic endonasal resection of craniopharyngiomas: comparison of gross-total resection versus subtotal resection with radiation therapy. J Neurosurg 2022; 136:1347-1355. [PMID: 34653972 DOI: 10.3171/2021.5.jns202011] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2020] [Accepted: 05/06/2021] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Surgical management of craniopharyngiomas (CPAs) is challenging. Controversy exists regarding the optimal goals of surgery. The purpose of this study was to compare the long-term outcomes of patients who underwent gross-total resection with the outcomes of those who underwent subtotal resection of their CPA via an endoscopic endonasal approach. METHODS From a prospectively maintained database of all endoscopic endonasal approaches performed at Weill Cornell Medicine, only patients with CPAs with > 3 years of follow-up after surgery were included. The primary endpoint was radiographic progression. Data were collected on baseline demographics, imaging, endocrine function, visual function, and extent of resection. RESULTS A total of 44 patients with a mean follow-up of 5.7 ± 2.6 years were included. Of these patients, 14 (31.8%) had prior surgery. GTR was achieved in 77.3% (34/44) of all patients and 89.5% (34/38) of patients in whom it was the goal of surgery. Preoperative tumor volume < 10 cm3 was highly predictive of GTR (p < 0.001). Radiation therapy was administered within the first 3 months after surgery in 1 (2.9%) of 34 patients with GTR and 7 (70%) of 10 patients with STR (p < 0.001). The 5-year recurrence-free/progression-free survival rate was 75.0% after GTR and 25.0% after STR (45% in subgroup with STR plus radiotherapy; p < 0.001). The time to recurrence after GTR was 30.2 months versus 13 months after STR (5.8 months in subgroup with STR plus radiotherapy; p < 0.001). Patients with GTR had a lower rate of visual deterioration and higher rate of return to work or school compared with those with STR (p = 0.02). Patients with GTR compared to STR had a lower rate of CSF leakage (0.0% vs 30%, p = 0.001) but a higher rate of diabetes insipidus (85.3% vs 50%, p = 0.02). CONCLUSIONS GTR, which is possible to achieve in smaller tumors, resulted in improved tumor control, better visual outcome, and better functional recovery but a higher rate of diabetes insipidus compared with STR, even when the latter was supplemented with postoperative radiation therapy. GTR should be the goal of craniopharyngioma surgery, when achievable with minimal morbidity.
Collapse
Affiliation(s)
- Saniya S Godil
- 1Department of Neurosurgery, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York
- 2Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Umberto Tosi
- 1Department of Neurosurgery, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York
| | - Mina Gerges
- 1Department of Neurosurgery, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York
- 3Department of Neurosurgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| | - Andrew L A Garton
- 1Department of Neurosurgery, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York
| | - Georgiana A Dobri
- 1Department of Neurosurgery, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York
- 4Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York; and
| | - Ashutosh Kacker
- 5Department of Otolaryngology, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York
| | - Abtin Tabaee
- 5Department of Otolaryngology, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York
| | - Vijay K Anand
- 5Department of Otolaryngology, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York
| | - Theodore H Schwartz
- 1Department of Neurosurgery, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York
- 5Department of Otolaryngology, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York
| |
Collapse
|
34
|
Lee WJ, Hong SD, Woo KI, Seol HJ, Choi JW, Lee JI, Nam DH, Kong DS. Combined endoscopic endonasal and transorbital multiportal approach for complex skull base lesions involving multiple compartments. Acta Neurochir (Wien) 2022; 164:1911-1922. [PMID: 35488013 DOI: 10.1007/s00701-022-05203-z] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2022] [Accepted: 03/30/2022] [Indexed: 12/25/2022]
Abstract
PURPOSE This study defines the specific areas that connect the surgical corridors of the endoscopic endonasal (EEA) and transorbital approach (TOA) to identify adequate clinical applications and perspectives of this combined multiportal approach. METHODS Consecutive patients who underwent combined EEA and TOA procedures for various pathologies involving multiple compartments of the skull base were enrolled. RESULTS A total of eight patients (2 chondrosarcomas, 2 meningiomas, 2 schwannomas, 1 glioma, and 1 traumatic optic neuropathy) were included between August 2016 and April 2021. The cavernous sinus (CS) was targeted as the connection area of the combined approach in four patients with tumors infiltrating the middle cranial fossa (MCF) and central skull base through the CS. For two patients with MCF tumors extending into the infratemporal fossa (ITF), the horizontal portion of the greater sphenoid wing and the foramen ovale were utilized as the connection area. In the remaining 2 patients, connection was achieved through the optic canal (OC). Gross total and near total resection was achieved in 5 patients with tumors, and circumferential removal of bone composing the OC was performed in one patient with traumatic compressive optic neuropathy. Postoperative complications included one cardiac arrest due to underlying cardiovascular disease and one case of oculomotor nerve palsy. CONCLUSIONS The combined EEA and TOA procedure is a useful strategy for complex lesions involving multiple compartments of the skull base. Herein, we identified the specific areas connecting the two surgical approaches, allowing a common path for EEA and TOA procedures.
Collapse
|
35
|
Carnevale JA, Babu CS, Goldberg JL, Fong R, Schwartz TH. Visual deterioration after endonasal endoscopic skull base surgery: causes, treatments, and outcomes. J Neurosurg 2022; 136:1103-1113. [PMID: 34598134 DOI: 10.3171/2021.3.jns204378] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Accepted: 03/23/2021] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Visual deterioration after endoscopic endonasal transsphenoidal surgery (EETS) for sellar and parasellar masses is a rare but serious complication caused by either compressive or ischemic mechanisms. Timely diagnosis and intervention may restore vision if instituted appropriately. The associated risk factors and their relation to the success of intervention are not well understood. METHODS The authors examined a series of 1200 consecutive EETS cases performed by the senior author at Weill Cornell/NewYork-Presbyterian Hospital from 2010 to 2020. Cases with postoperative visual deterioration were identified. Pre- and postoperative clinical data, mechanism of visual decline, latency to intervention, and long-term visual outcome were retrospectively collected and analyzed with appropriate statistical methods. RESULTS Twenty-one patients (1.75%) complained of early postoperative visual deterioration. The most common pathology associated with postoperative visual loss was craniopharyngioma (7.69%), followed by meningioma (5.43%) and then pituitary adenoma (1.94%). Timely intervention restored vision in 81% of patients for a 0.33% rate of permanent visual deterioration. Average time to visual deterioration was 28.8 hours, and over 70% of patients experienced vision loss within the first 13 hours. Compressive etiology (n = 11), consisting of either hematoma (n = 8) or graft displacement (n = 3), occurred 7.3 hours and 70.3 hours after surgery, respectively, and was more common in adenomas. Acute postoperative visual deterioration was more common in firm closures (4.78%) compared with soft closures (1.03%; p = 0.0006). Ischemic etiology (n = 10) occurred 10.3 hours after surgery and was more common with craniopharyngiomas and meningiomas (p = 0.08). Sixteen patients (76.2%) underwent early reoperation to explore and decompress the optic apparatus. Vision was restored to baseline after reoperation in all 11 compressive cases, whereas 6/10 ischemic cases improved with supplemental oxygen and hypervolemic hypertensive therapy (p = 0.02). Fluid expansion from 8 to 16 hours (p = 0.034) and systolic blood pressure elevation from 32 to 48 hours (p = 0.05) after surgery were significantly higher in those ischemic patients who recovered some vision compared with those with persistent visual deficits. CONCLUSIONS Visual deterioration after EETS is a rare event but can be effectively treated if acted upon appropriately and in a timely fashion. Compressive etiology is reversible with early reoperation. Ischemic etiology can be successfully treated in roughly half of cases with supplemental oxygen and hypertensive hypervolemic therapy but may result in permanent visual deterioration if not instituted appropriately or if delayed with unnecessary exploratory surgery.
Collapse
Affiliation(s)
| | | | | | | | - Theodore H Schwartz
- Departments of1Neurological Surgery
- 3Neuroscience, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York
| |
Collapse
|
36
|
Rutland JW, Dullea JT, Oermann EK, Feng R, Villavisanis DF, Gilja S, Shuman W, Lander T, Govindaraj S, Iloreta AMC, Chelnis J, Post K, Bederson JB, Shrivastava RK. Post-operative vision loss: analysis of 587 patients undergoing endoscopic surgery for pituitary macroadenoma. Br J Neurosurg 2022; 36:494-500. [PMID: 35264032 DOI: 10.1080/02688697.2022.2047888] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
PURPOSE Vision loss following surgery for pituitary adenoma is poorly described in the literature and cannot be reliably predicted with current prognostic models. Detailed characterization of this population is warranted to further understand the factors that predispose a minority of patients to post-operative vision loss. MATERIALS AND METHODS The medical records of 587 patients who underwent endoscopic transsphenoidal surgery at the Mount Sinai Medical Centre between January 2013 and August 2018 were reviewed. Patients who experienced post-operative vision deterioration, defined by reduced visual acuity, worsened VFDs, or new onset of blurry vision, were identified and analysed. RESULTS Eleven out of 587 patients who received endoscopic surgery for pituitary adenoma exhibited post-operative vision deterioration. All eleven patients presented with preoperative visual impairment (average duration of 13.1 months) and pre-operative optic chiasm compression. Seven patients experienced visual deterioration within 24 h of surgery. The remaining four patients experienced delayed vision loss within one month of surgery. Six patients had complete blindness in at least one eye, one patient had complete bilateral blindness. Four patients had reduced visual acuity compared with preoperative testing, and four patients reported new-onset blurriness that was not present before surgery. High rates of graft placement (10/11 patients) and opening of the diaphragma sellae (9/11 patients) were found in this series. Four patients had hematomas and four patients had another significant post-operative complication. CONCLUSIONS While most patients with pituitary adenoma experience favourable ophthalmological outcomes following endoscopic transsphenoidal surgery, a subset of patients exhibit post-operative vision deterioration. The present study reports surgical and disease features of this population to further our understanding of factors that may underlie vision loss following pituitary adenoma surgery. Graft placement and opening of the diaphragma sellae may be important risk factors in vision loss following ETS and should be an area of future investigation.
Collapse
Affiliation(s)
- John W Rutland
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Jonathan T Dullea
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Eric K Oermann
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Rui Feng
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Dillan F Villavisanis
- Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Shivee Gilja
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - William Shuman
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Travis Lander
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Satish Govindaraj
- Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Alfred M C Iloreta
- Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - James Chelnis
- Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Kalmon Post
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Joshua B Bederson
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Raj K Shrivastava
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| |
Collapse
|
37
|
Zagzoog N, Zadeh G, Lin V, Yang VXD. Perspective review on applications of optics in skull base surgery. Clin Neurol Neurosurg 2021; 212:107085. [PMID: 34894572 DOI: 10.1016/j.clineuro.2021.107085] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2021] [Revised: 11/26/2021] [Accepted: 11/29/2021] [Indexed: 11/19/2022]
Abstract
The use of optic technology in skull base surgeries has the potential to revolutionize the field of medicine, particularly neurosurgery and neurology. Here, we briefly present the past, present, and future of skull-base surgery, with an emphasis on the applications of optical topography techniques. We discuss optical topography techniques such as functional near-infrared spectroscopy, optical diffusion tomography, and optical topographical imaging. Optical topography techniques are particularly advantageous when combined with other imaging methods. For instance, optical topography can be combined with techniques such as functional magnetic resonance imaging (fMRI) to combine the temporal resolution of optical topography with the spatial resolution of fMRI. Multimodal approaches will be critical to advance brain-related research as well as medicine. Structured light imaging techniques are also writing the future of 3-dimensional imaging. In short, optical topography can allow for non-invasive, high-resolution imaging that will provide real-time visualizations of the brain that are ideal for neurosurgery. From the limitations of traditional skull base surgeries to the newest developments in optical neuroimaging, here we will discuss the potential applications of optics in skull base procedures.
Collapse
Affiliation(s)
- Nirmeen Zagzoog
- Institute of Medical Science, School of Graduate Studies, Faculty of Medicine, Toronto, Ontario, Canada; Sunnybrook Health Sciences Centre, Brain Sciences Program/Imaging Research, Sunnybrook Research Institute, Toronto, Ontario, Canada; Division of Neurosurgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
| | - Gelareh Zadeh
- Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Division of Neurosurgery, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada
| | - Vincent Lin
- Department of Otolaryngology - Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada; Department of Otolaryngology - Head and Neck Surgery, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
| | - Victor X D Yang
- Sunnybrook Health Sciences Centre, Brain Sciences Program/Imaging Research, Sunnybrook Research Institute, Toronto, Ontario, Canada; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Ryerson University, Bioengineering and Biophotonics Laboratory, Toronto, Ontario, Canada
| |
Collapse
|
38
|
Teng C, Yang Q, Xiong Z, Ye N, Li X. Multivariate Analysis and Validation of the Prognostic Factors for Skull Base Chordoma. Front Surg 2021; 8:764329. [PMID: 34888345 PMCID: PMC8649658 DOI: 10.3389/fsurg.2021.764329] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2021] [Accepted: 10/18/2021] [Indexed: 11/13/2022] Open
Abstract
Background: Skull base chordoma is a rare tumor with low-grade malignancy and a high recurrence rate, the factors affecting the prognosis of patients need to be further studied. For that, we investigated prognostic factors of skull base chordoma through the database of the Surveillance, Epidemiology, and End Results (SEER) program, and validated in an independent data set from the Xiangya Hospital. Methods: Six hundred and forty-three patients diagnosed with skull base chordoma were obtained from the SEER database (606 patients) and the Xiangya Hospital (37 patients). Categorical variables were selected by Chi-square test with a statistical difference. Survival curves were constructed by Kaplan–Meier analysis and compared by log-rank test. Univariate and multivariate Cox regression analyses were used to explore the prognostic factors. Propensity score matching (PSM) analysis was undertaken to reduce the substantial bias between gross total resection (GTR) and subtotal resection (STR) groups. Furthermore, clinical data of 37 patients from the Xiangya Hospital were used as validation cohorts to check the survival impacts of the extent of resection and adjuvant radiotherapy on prognosis. Results: We found that age at diagnosis, primary site, disease stage, surgical treatment, and tumor size was significantly associated with the prognosis of skull base chordoma. PSM analysis revealed that there was no significant difference in the OS between GTR and STR (p = 0.157). Independent data set from the Xiangya Hospital proved no statistical difference in OS between GTR and STR groups (p = 0.16), but the GTR group was superior to the STR group for progression-free survival (PFS) (p = 0.048). Postoperative radiotherapy does not improve OS (p = 0.28), but it can prolong PFS (p = 0.0037). Nomograms predicting 5- and 10-year OS and DSS were constructed based on statistically significant factors identified by multivariate Cox analysis. Age, primary site, tumor size, surgical treatment, and disease stage were included as prognostic predictors in the nomograms with good performance. Conclusions: We identified age, tumor size, surgery, primary site, and tumor stage as main factors affecting the prognosis of the skull base chordoma. Resection of the tumor as much as possible while ensuring safety, combined with postoperative radiotherapy may be the optimum treatment for skull base chordoma.
Collapse
Affiliation(s)
- Chubei Teng
- Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.,Hunan International Scientific and Technological Cooperation Base of Brain Tumor Research, Xiangya Hospital, Central South University, Changsha, China.,Department of Neurosurgery, The First Affiliated Hospital, University of South China, Hengyang, China
| | - Qi Yang
- Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.,Hunan International Scientific and Technological Cooperation Base of Brain Tumor Research, Xiangya Hospital, Central South University, Changsha, China
| | - Zujian Xiong
- Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.,Hunan International Scientific and Technological Cooperation Base of Brain Tumor Research, Xiangya Hospital, Central South University, Changsha, China
| | - Ningrong Ye
- Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.,Hunan International Scientific and Technological Cooperation Base of Brain Tumor Research, Xiangya Hospital, Central South University, Changsha, China
| | - Xuejun Li
- Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.,Hunan International Scientific and Technological Cooperation Base of Brain Tumor Research, Xiangya Hospital, Central South University, Changsha, China
| |
Collapse
|
39
|
Henderson F, Schwartz TH. Update on management of craniopharyngiomas. J Neurooncol 2021; 156:97-108. [PMID: 34807341 DOI: 10.1007/s11060-021-03906-4] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2021] [Accepted: 11/17/2021] [Indexed: 02/03/2023]
Abstract
PURPOSE/INTRODUCTION Craniopharyngiomas are locally-aggressive tumors arising along the hypothalamic-pituitary axis. Treatment is nuanced as a result of their proximity and adherence to vital neurovascular structures and responsiveness to surgery, radiation and, in some cases, chemotherapy. METHODS We reviewed the literature discussing the current state of knowledge regarding craniopharyngioma biology and therapy. RESULTS Recent advances in endoscopic endonasal surgery (EEA) have made surgery a safer and more effective option. While cure may be achieved with gross total resection (GTR), when felt to be too risky, a subtotal resection followed by radiation is often a more prudent strategy, particularly in children with hypothalamic invasion. Data on long-term outcome are mostly derived from older studies in which a craniotomy, rather than EEA, was performed. Long-term EEA outcome studies are lacking. Enhanced knowledge of the biological basis of papillary CPs has led to novel medical treatments for BRAFv600E variants that appear to be effective. CONCLUSION Endoscopic technology has improved surgical results for craniopharyngiomas and expanded the indications for the transsphenoidal approach. The goal of CP surgery goal is maximal safe resection to achieve cure, but subtotal resection and radiation may be equally effective. Early diagnosis of specific variants will facilitate enrollment in promising medical trials.
Collapse
Affiliation(s)
- Fraser Henderson
- Department of Neurological Surgery, Weill Cornell Medicine, NewYork-Presbyterian Hospital, 525 East 68th St, Box #99, New York, NY, 10065, USA
| | - Theodore H Schwartz
- Department of Neurological Surgery, Weill Cornell Medicine, NewYork-Presbyterian Hospital, 525 East 68th St, Box #99, New York, NY, 10065, USA.
| |
Collapse
|
40
|
Khalafallah AM, Rakovec M, Burapachaisri K, Fung S, Kozachik SL, Valappil B, Abou-Al-Shaar H, Wang EW, Snyderman CH, Zenonos GA, Gardner PA, Baskaya MK, Dornbos D, Choby G, Kuan EC, Roxbury C, Overdevest JB, Gudis DA, Lee VS, Levy JM, Thamboo A, Schlosser RJ, Huang J, Bettegowda C, London NR, Rowan NR, Wu AW, Mukherjee D. The Suprasellar Meningioma Patient-Reported Outcome Survey: a disease-specific patient-reported outcome measure for resection of suprasellar meningioma. J Neurosurg 2021:1-9. [PMID: 34874673 DOI: 10.3171/2021.6.jns21517] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2021] [Accepted: 06/16/2021] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Suprasellar meningioma resection via either the transcranial approach (TCA) or the endoscopic endonasal approach (EEA) is an area of controversy and active evaluation. Skull base surgeons increasingly consider patient-reported outcomes (PROs) when choosing an approach. No PRO measure currently exists to assess quality of life for suprasellar meningiomas. METHODS Adult patients undergoing suprasellar meningioma resection between 2013 and 2019 via EEA (n = 14) or TCA (n = 14) underwent semistructured interviews. Transcripts were coded using a grounded theory approach to identify themes as the basis for a PRO measure that includes all uniquely reported symptoms. To assess content validity, 32 patients and 15 surgeons used a Likert scale to rate the relevance of items on the resulting questionnaire and the general Patient-Reported Outcomes Measurement Information System-29 (PROMIS29). The mean scores were calculated for all items and compared for TCA versus EEA patient cohorts by using unpaired t-tests. Items on either questionnaire with mean scores ≥ 2.0 from patients were considered meaningful and were aggregated to form the novel Suprasellar Meningioma Patient-Reported Outcome Survey (SMPRO) instrument. RESULTS Qualitative analyses resulted in 55 candidate items. Relative to patients who underwent the EEA, those who underwent the TCA reported significantly worse future outlook before surgery (p = 0.01), tiredness from medications 2 weeks after surgery (p = 0.001), and word-finding and memory difficulties 3 months after surgery (p = 0.05 and < 0.001, respectively). The items that patients who received a TCA were most concerned about included medication-induced lethargy after surgery (2.9 ± 1.3), blurry vision before surgery (2.7 ± 1.5), and difficulty reading due to blurry vision before surgery (2.7 ± 2.7). Items that patients who received an EEA were most concerned about included blurry vision before surgery (3.5 ± 1.3), difficulty reading due to blurry vision before surgery (2.4 ± 1.3), and problems with smell postsurgery (2.9 ± 1.3). Although surgeons overall overestimated how concerned patients were about questionnaire items (p < 0.0005), the greatest discrepancies between patient and surgeon relevance scores were for blurry vision pre- and postoperatively (p < 0.001 and < 0.001, respectively) and problems with taste postoperatively (p < 0.001). Seventeen meningioma-specific items were considered meaningful, supplementing 8 significant PROMIS29 items to create the novel 25-item SMPRO. CONCLUSIONS The authors developed a disease- and approach-specific measure for suprasellar meningiomas to compare quality of life by operative approach. If demonstrated to be reliable and valid in future studies, this instrument may assist patients and providers in choosing a personalized surgical approach. ABBREVIATIONS EEA = endoscopic endonasal approach; GTR = gross-total resection; PRO = patient-reported outcome; PROMIS29 = Patient-Reported Outcomes Measurement Information System-29; QOL = quality of life; SMPRO = Suprasellar Meningioma Patient-Reported Outcome Survey; TCA = transcranial approach.
Collapse
Affiliation(s)
| | - Maureen Rakovec
- Department of Neurosurgery, Johns Hopkins University School of Medicine
| | | | - Shirley Fung
- Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland
| | - Sharon L. Kozachik
- Medical University of South Carolina College of Nursing, Charleston, South Carolina
| | - Benita Valappil
- Department of Otolaryngology, University of Pittsburgh School of Medicine
| | - Hussam Abou-Al-Shaar
- Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
| | - Eric W. Wang
- Department of Otolaryngology, University of Pittsburgh School of Medicine
| | - Carl H. Snyderman
- Department of Otolaryngology, University of Pittsburgh School of Medicine
| | - Georgios A. Zenonos
- Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
| | - Paul A. Gardner
- Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
| | - Mustafa K. Baskaya
- Department of Neurosurgery, University of Wisconsin–Madison School of Medicine and Public Health, Madison, Wisconsin
| | - David Dornbos
- Department of Neurological Surgery, Ohio State University Medical Center, Columbus, Ohio
| | - Garrett Choby
- Department of Otorhinolaryngology–Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota
| | - Edward C. Kuan
- Department of Otolaryngology–Head and Neck Surgery, University of California, Irvine, Orange, California
| | - Christopher Roxbury
- Department of Surgery, Section of Otolaryngology–Head and Neck Surgery, University of Chicago School of Medicine, Chicago, Illinois
| | - Jonathan B. Overdevest
- Department of Otolaryngology–Head and Neck Surgery, Columbia University Irving Medical Center, New York, New York
| | - David A. Gudis
- Department of Otolaryngology–Head and Neck Surgery, University of Illinois at Chicago, Illinois
| | - Victoria S. Lee
- Department of Otolaryngology–Head and Neck Surgery, University of Illinois at Chicago, Illinois
| | - Joshua M. Levy
- Department of Otolaryngology–Head and Neck Surgery, Division of Rhinology and Anterior Skull Base, Emory University Hospital, Atlanta, Georgia
| | - Andrew Thamboo
- Department of Otolaryngology–Head and Neck Surgery, Stanford University School of Medicine, Stanford, California
| | - Rodney J, Schlosser
- Department of Otolaryngology–Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina
| | - Judy Huang
- Department of Neurosurgery, Johns Hopkins University School of Medicine
| | - Chetan Bettegowda
- Department of Neurosurgery, Johns Hopkins University School of Medicine
| | - Nyall R. London
- Department of Otolaryngology–Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - Nicholas R. Rowan
- Department of Otolaryngology–Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - Albert W. Wu
- Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland
| | - Debraj Mukherjee
- Department of Neurosurgery, Johns Hopkins University School of Medicine
| |
Collapse
|
41
|
Xiao F, Shen J, Zhang L, Yang J, Weng Y, Fang Z, Zhang C, Ye H, Zhan R, Zheng X. Unilateral Subfrontal Approach for Giant Tuberculum Sellae Meningioma: Single Center Experience and Review of the Literature. Front Oncol 2021; 11:708235. [PMID: 34434897 PMCID: PMC8381050 DOI: 10.3389/fonc.2021.708235] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2021] [Accepted: 07/19/2021] [Indexed: 11/13/2022] Open
Abstract
Background Microsurgical Transcranial approach (mTCA) is the primary choice for the resection of giant Tuberculum Sellae Meningiomas (TSM). The objective of this study is to explore surgical details of unilateral subfrontal approach. Methods Ten patients with giant TSM treated by unilateral subfrontal approach were included from January 2018 to June 2021. Demographic characteristics, surgical data, post-procedure complications and outcomes of patients have been descriptive analyzed, combined with systematic literature review to explore the surgical details and the prognosis of unilateral subfrontal approach. Results Ten patients include six male and four females, age range from 35 to 77 years, duration of visual impairment from 1 to 12 months, were all performed unilateral subfrontal approach. Nine patients achieved radical resection (Simpson grades I-II) through post-operative imaging confirmation, and Simpson IV resection was performed in the remaining one due to cavernous sinus invasion. The postoperative visual acuity was improved or maintained in 8 patients. Visual acuity decreased in 2 cases, including 1 case of optic nerve atrophy and the other case of optic canal not opening. Five cases with frontal sinus opened were repaired during the operation and there was no postoperative cerebrospinal fluid leakage or intracranial infection. One patient suffered from postoperative anosmia, one patient developed left limb weakness, but their symptoms have improved in the follow-up. Conclusion Summarize the experience of our center and previous literature, unilateral forehead bottom craniotomy is a feasible surgical approach for giant tuberculum sellae meningioma. Intraoperative application of EC glue and pedicled fascia flap to repair the frontal sinus can prevent complications associated with frontal sinus opening. Optic canal unroofing has huge advantage in visual improvement.
Collapse
Affiliation(s)
- Feng Xiao
- Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Jie Shen
- Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Luyuan Zhang
- Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Jiqi Yang
- Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Yuxiang Weng
- Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Zebin Fang
- Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Chao Zhang
- Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Hongxing Ye
- Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Renya Zhan
- Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Xiujue Zheng
- Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| |
Collapse
|
42
|
Reddy RK, Gill AS, Hwang J, Wilson MD, Shahlaie K, Harsh GR, Strong EB, Steele TO. Surgeon education through a surgical cost feedback system reduces supply cost in endoscopic skull base surgery. J Neurosurg 2021; 136:422-430. [PMID: 34388725 DOI: 10.3171/2021.2.jns203208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2020] [Accepted: 02/02/2021] [Indexed: 11/06/2022]
Abstract
OBJECTIVE A large proportion of healthcare expense is operating room (OR) costs. As a means of cost mitigation, several institutions have implemented surgeon education programs to bring awareness about supply costs. This study evaluates the impact of a surgical cost feedback system (surgical receipt) on the supply costs of endoscopic skull base surgery (ESBS) procedures. METHODS The supply costs of each ESBS surgical case were prospectively collected and analyzed before and after the implementation of a nonincentivized, automated, and itemized weekly surgical receipt system between January 2017 and December 2019. Supply cost data collected 15 months prior to intervention were compared with cost data 21 months after implementation of the surgical receipt system. Demographics, surgical details, and OR time were collected retrospectively. RESULTS Of 105 ESBS procedures analyzed, 36 preceded and 69 followed implementation of cost feedback. There were no significant differences in patient age (p = 0.064), sex (p = 0.489), surgical indication (p = 0.389), or OR anesthesia time (p = 0.51) for patients treated before and after implementation. The mean surgical supply cost decreased from $3824.41 to $3010.35 (p = 0.002) after implementation of receipt feedback. Usage of dural sealants (p = 0.043), microfibrillar collagen hemostat (p = 0.007), and oxidized regenerated cellulose hemostat (p < 0.0001) and reconstructive technique (p = 0.031) significantly affected cost. Mediation analysis confirmed that the overall cost reduction was predominantly driven by reduced use of dural sealant; this cost saving exceeded the incremental cost of greater use of packing materials such as microfibrillar collagen hemostat. CONCLUSIONS Education of surgeons regarding surgical supply costs by a surgical receipt feedback system can reduce the supply cost per case of ESBS operations.
Collapse
Affiliation(s)
- Renuka K Reddy
- 1University of California Davis Department of Otolaryngology-Head and Neck Surgery, Sacramento
| | - Amarbir S Gill
- 1University of California Davis Department of Otolaryngology-Head and Neck Surgery, Sacramento
| | - Joshua Hwang
- 1University of California Davis Department of Otolaryngology-Head and Neck Surgery, Sacramento
| | - Machelle D Wilson
- 3Department of Public Health Sciences/Biostatistics, Clinical and Translational Science Center, University of California Davis, Sacramento; and
| | - Kiarash Shahlaie
- 2University of California Davis Department of Neurological Surgery, Sacramento
| | - Griffith R Harsh
- 2University of California Davis Department of Neurological Surgery, Sacramento
| | - E Bradley Strong
- 1University of California Davis Department of Otolaryngology-Head and Neck Surgery, Sacramento
| | - Toby O Steele
- 1University of California Davis Department of Otolaryngology-Head and Neck Surgery, Sacramento.,4VA Northern California Healthcare System, Sacramento, California
| |
Collapse
|
43
|
Ceylan S, Emengen A, Caklili M, Ergen A, Yılmaz E, Uzuner A, Icli D, Cabuk B, Anik I. Operative nuances and surgical limits of the endoscopic approach to clival chordomas and chondrosarcomas: A single-center experience of 72 patients. Clin Neurol Neurosurg 2021; 208:106875. [PMID: 34388599 DOI: 10.1016/j.clineuro.2021.106875] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2021] [Revised: 07/24/2021] [Accepted: 08/02/2021] [Indexed: 10/20/2022]
Abstract
OBJECTIVE Gross total resection (GTR) is the mainstay therapy for chordomas and chondrosarcomas to have the best prognosis. The aims of this study were to specify the limits of EEA, emphasize the need for additional combined approaches for tumors beyond these limitations for high resection rates, discuss the prognostic factors and operative nuances that affect GTR, and present the causes and characteristics of early and late recurrences. METHODS We retrospectively analyzed the endoscopic endonasal surgeries in the Pituitary Research Center and Neurosurgery Department of the Kocaeli University Faculty of Medicine, Turkey between January 2004 and December 2019. We retrospectively reviewed the medical data, radiological images, and surgical videos of patients, and 72 patients with chordoma and chondrosarcoma were included in the study. RESULTS Based on pathology reports, 72 patients (seven pediatric) were identified, to whom 91 endoscopic operations were performed. We determined the surgical limitations for each clival segment as superior, middle, and inferior. Then, we divided these into three subgroups according to whether the tumor shows dural invasion (extradural chordoma, large extradural - minimal intradural component, and minimal extradural - large intradural component). The tumors of 19 (26.4%), 25 (26.4%), and nine (12.5%) patients originated from the superior, middle, and inferior clivus, respectively. Nineteen (26.4%) patients had panclival involvement. GTR was performed in 47 (65.3%) the patients. The GTR rate in patients with panclival tumors was 47.3% (9/19). The experience, lateralization, dural involvement, and origin of the clivus affecting GTR were analyzed. Extradural - intradural extensions were verified as negative predictor factors for GTR, whereas tumors located in the superior (OR: 16.710, p=0.030) and middle (OR: 11.154, p=0.023) segments were positive predictive factors for GTR. CONCLUSION An increasing experience in endoscopic surgery significantly increases the GTR rates by widening the surgical limitations. Due to dense bone infiltration and adhesion to critical neurovascular structures, recurrence rates are high despite performing GTR. Although surgery and adjuvant treatments improve the 5-year survival of patients, the mortality rates remain high. Therefore, surgery of these tumors should be performed by experienced centers. In addition to surgical and adjuvant therapies, targeted molecular and translational biological therapies are also needed for chordomas and chondrosarcomas in the future.
Collapse
Affiliation(s)
- Savas Ceylan
- Kocaeli University, Neurosurgery Department, Pituitary Research Center, Kocaeli, Turkey.
| | - Atakan Emengen
- Kocaeli State Hospital, Neurosurgery Department, Kocaeli, Turkey
| | - Melih Caklili
- Taksim Education and Research Hospital, Neurosurgery Department, Istanbul, Turkey
| | - Anil Ergen
- Kocaeli University, Neurosurgery Department, Pituitary Research Center, Kocaeli, Turkey
| | - Eren Yılmaz
- Kocaeli University, Neurosurgery Department, Pituitary Research Center, Kocaeli, Turkey
| | - Ayse Uzuner
- Kocaeli University, Neurosurgery Department, Pituitary Research Center, Kocaeli, Turkey
| | - Dilek Icli
- Kocaeli University, Department of Anesthesiology and Reanimation, Kocaeli, Turkey
| | - Burak Cabuk
- Kocaeli University, Neurosurgery Department, Pituitary Research Center, Kocaeli, Turkey
| | - Ihsan Anik
- Kocaeli University, Neurosurgery Department, Pituitary Research Center, Kocaeli, Turkey
| |
Collapse
|
44
|
Micko A, Rapoport BI, Youngerman BE, Fong RP, Kosty J, Brunswick A, Shahrestani S, Zada G, Schwartz TH. Limited utility of 5-ALA optical fluorescence in endoscopic endonasal skull base surgery: a multicenter retrospective study. J Neurosurg 2021; 135:535-541. [PMID: 33126212 DOI: 10.3171/2020.5.jns201171] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Accepted: 05/18/2020] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Incomplete resection of skull base pathology may result in local tumor recurrence. This study investigates the utility of 5-aminolevulinic acid (5-ALA) fluorescence during endoscopic endonasal approaches (EEAs) to increase visibility of pathologic tissue. METHODS This retrospective multicenter series comprises patients with planned resection of an anterior skull base lesion who received preoperative 5-ALA at two tertiary care centers. Diagnostic use of a blue light endoscope was performed during EEA for all cases. Demographic and tumor characteristics as well as fluorescence status, quality, and homogeneity were assessed for each skull base pathology. RESULTS Twenty-eight skull base pathologies underwent blue-light EEA with preoperative 5-ALA, including 15 pituitary adenomas (54%), 4 meningiomas (14%), 3 craniopharyngiomas (11%), 2 Rathke's cleft cysts (7%), as well as plasmacytoma, esthesioneuroblastoma, and sinonasal squamous cell carcinoma. Of these, 6 (21%) of 28 showed invasive growth into surrounding structures such as dura, bone, or compartments of the cavernous sinus. Tumor fluorescence was detected in 2 cases (7%), with strong fluorescence in 1 tuberculum sellae meningioma and vague fluorescence in 1 pituicytoma. In all other cases fluorescence was absent. Faint fluorescence of the normal pituitary gland was seen in 1 (7%) of 15 cases. A comparison between the particular tumor entities as well as a correlation between invasiveness, WHO grade, Ki-67, and positive fluorescence did not show any significant association. CONCLUSIONS With the possible exception of meningiomas, 5-ALA fluorescence has limited utility in the majority of endonasal skull base surgeries, although other pathology may be worth investigating.
Collapse
Affiliation(s)
- Alexander Micko
- 1Department of Neurosurgery, Medical University of Vienna, Austria
- 2Department of Neurosurgery, Keck School of Medicine, University of Southern California, Los Angeles, California; and
| | - Benjamin I Rapoport
- 3Department of Neurological Surgery, NewYork-Presbyterian Hospital/Weill Cornell Medicine, New York, New York
| | - Brett E Youngerman
- 3Department of Neurological Surgery, NewYork-Presbyterian Hospital/Weill Cornell Medicine, New York, New York
| | - Reginald P Fong
- 3Department of Neurological Surgery, NewYork-Presbyterian Hospital/Weill Cornell Medicine, New York, New York
| | - Jennifer Kosty
- 3Department of Neurological Surgery, NewYork-Presbyterian Hospital/Weill Cornell Medicine, New York, New York
| | - Andrew Brunswick
- 2Department of Neurosurgery, Keck School of Medicine, University of Southern California, Los Angeles, California; and
| | - Shane Shahrestani
- 2Department of Neurosurgery, Keck School of Medicine, University of Southern California, Los Angeles, California; and
| | - Gabriel Zada
- 2Department of Neurosurgery, Keck School of Medicine, University of Southern California, Los Angeles, California; and
| | - Theodore H Schwartz
- 3Department of Neurological Surgery, NewYork-Presbyterian Hospital/Weill Cornell Medicine, New York, New York
| |
Collapse
|
45
|
Zhu J, Feng K, Tang C, Yang J, Cai X, Zhong C, Ma C. Olfactory outcomes after endonasal skull base surgery: a systematic review. Neurosurg Rev 2021; 44:1805-1814. [PMID: 32914235 DOI: 10.1007/s10143-020-01385-1] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2020] [Revised: 08/18/2020] [Accepted: 09/03/2020] [Indexed: 11/26/2022]
Abstract
For the last two decades, endonasal approach has been regularly applied to treat skull base lesions. However, postoperative olfactory dysfunction remains an unsolved problem. This systematic review aimed to identify factors that might affect postoperative olfactory prognosis of patients undergoing endonasal surgery for resection of sellar/parasellar lesions. The literature search was conducted comprehensively to exhaust studies which focused on patients' olfaction with objective olfactory assessments after endonasal skull base surgery. We sought to characterize the potential factors that might affect postoperative olfactory outcomes. Nineteen articles met inclusion criteria. We found that (1) endoscopic surgery was beneficial to patients' olfactory prognosis than microscopic surgery (incidence of postoperative decreased olfactory function: 18.48% (39/211) for the endoscopic group and 36.88% (52/141) for the microscopic group, P < 0.01); meta-analysis for single rate, 20% (95% CI 9-30%) for the endoscopic group and 35% (95% CI 0-72%) for the microscopic group); (2) harvesting septal flaps was an unfavorable factor for olfactory recovery and the rescue flap technique should be preferred compared with the HB flap; (3) no evidence showed that resection of the middle turbinate was detrimental to recovery of olfaction. Patients undergoing endoscopic endonasal surgery may have better olfactory outcomes than those undergoing microscopic endonasal surgery for resection of sellar/parasellar lesions. Special attention should be paid when using septal flaps is planned and the rescue flap technique should be the preferred choice. After resecting the middle turbinate, patients' olfaction still has a great chance of returning to the baseline. More homogeneous and high-quality studies are needed for further assessment.
Collapse
Affiliation(s)
- Junhao Zhu
- Jinling Hospital, School of Medicine, Nanjing Medical University, 104 Hanzhong Road, Nanjing, 210002, China
- Department of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, 305 East Zhongshan Road, Nanjing, 210002, China
| | - Kaiyang Feng
- Arkansas College of Health Education, 7000 Chad Colley Blvd, Fort Smith, AR, 72916, USA
| | - Chao Tang
- Department of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, 305 East Zhongshan Road, Nanjing, 210002, China
| | - Jin Yang
- Jinling Hospital, School of Medicine, Nanjing Medical University, 104 Hanzhong Road, Nanjing, 210002, China
- Department of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, 305 East Zhongshan Road, Nanjing, 210002, China
| | - Xiangming Cai
- School of Medicine, Southeast University, Nanjing, 210009, China
| | - Chunyu Zhong
- Jinling Hospital, School of Medicine, Nanjing Medical University, 104 Hanzhong Road, Nanjing, 210002, China
- Department of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, 305 East Zhongshan Road, Nanjing, 210002, China
| | - Chiyuan Ma
- Jinling Hospital, School of Medicine, Nanjing Medical University, 104 Hanzhong Road, Nanjing, 210002, China.
- Department of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, 305 East Zhongshan Road, Nanjing, 210002, China.
| |
Collapse
|
46
|
Youngerman BE, Banu MA, Gerges MM, Odigie E, Tabaee A, Kacker A, Anand VK, Schwartz TH. Endoscopic endonasal approach for suprasellar meningiomas: introduction of a new scoring system to predict extent of resection and assist in case selection with long-term outcome data. J Neurosurg 2021; 135:113-125. [PMID: 32707549 PMCID: PMC8111689 DOI: 10.3171/2020.4.jns20475] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2020] [Accepted: 04/27/2020] [Indexed: 11/06/2022]
Abstract
OBJECTIVE The endoscopic endonasal approach (EEA) has gained increasing popularity for the resection of suprasellar meningiomas (SSMs). Appropriate case selection is critical in optimizing patient outcome. Long-term outcome data are lacking. The authors systematically identified preoperative factors associated with extent of resection (EOR) and determined the relationship between EOR and long-term recurrence after EEA for SSMs. METHODS In this retrospective cohort study, the authors identified preoperative clinical and imaging characteristics associated with EOR and built on the recently published University of California, San Francisco resectability score to propose a score more specific to the EEA. They then examined the relationship between gross-total resection (GTR; 100%), near-total resection (NTR; 95%-99%), and subtotal resection (STR; < 95%) and recurrence or progression with Kaplan-Meier survival analysis. RESULTS A total of 51 patients were identified. Radiographic GTR was achieved in 40 of 47 (85%) patients in whom it was the surgical goal. Significant independent risk factors for incomplete resection were prior surgery (OR 25.94, 95% CI < 2.00 to 336.49, p = 0.013); tumor lateral to the optic nerve (OR 13.41, 95% CI 1.82-98.99, p = 0.011); and complete internal carotid artery (ICA) encasement (OR 15.12, 95% CI 1.17-194.08, p = 0.037). Tumor size and optic canal invasion were not significant risk factors after adjustment for other variables. A resectability score based on the multivariable model successfully predicted the likelihood of GTR; a score of 0 had a positive predictive value of 97% for GTR, whereas a score of 2 had a negative predictive value of 87.5% for incomplete resection. After a mean follow-up of 40.6 ± 32.4 months (mean ± SD), recurrence was 2.7% after GTR (1 patient with atypical histology), 44.4% after NTR, and 80% after STR (p < 0.0001). Vision was stable or improved in 93.5% and improved in 67.4% of patients with a preoperative deficit. There were 5 (9.8%) postoperative CSF leaks, of which 4 were managed with lumbar drains and 1 required a reoperation. CONCLUSIONS The EEA is a safe and effective approach to SSMs, with favorable visual outcomes in well-selected cases. The combination of postoperative MRI-based EOR with direct endoscopic inspection can be used in lieu of Simpson grade to predict recurrence. GTR dramatically reduces recurrence and can be achieved regardless of tumor size, proximity or encasement of the anterior cerebral artery, or medial optic canal invasion. Risk factors for incomplete resection include prior surgery, tumor lateral to the optic nerve, and complete ICA encasement.
Collapse
Affiliation(s)
- Brett E. Youngerman
- Departments of Neurosurgery Weill Cornell Medicine, NewYork-Presbyterian Hospital
- Department of Neurosurgery, Columbia University Medical Center, NewYork-Presbyterian Hospital, New York, New York
| | - Matei A. Banu
- Department of Neurosurgery, Columbia University Medical Center, NewYork-Presbyterian Hospital, New York, New York
| | - Mina M. Gerges
- Departments of Neurosurgery Weill Cornell Medicine, NewYork-Presbyterian Hospital
- Department of Neurosurgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| | - Eseosa Odigie
- Departments of Neurosurgery Weill Cornell Medicine, NewYork-Presbyterian Hospital
| | - Abtin Tabaee
- Otolaryngology Weill Cornell Medicine, NewYork-Presbyterian Hospital
| | - Ashutosh Kacker
- Otolaryngology Weill Cornell Medicine, NewYork-Presbyterian Hospital
| | - Vijay K. Anand
- Otolaryngology Weill Cornell Medicine, NewYork-Presbyterian Hospital
| | - Theodore H. Schwartz
- Departments of Neurosurgery Weill Cornell Medicine, NewYork-Presbyterian Hospital
- Otolaryngology Weill Cornell Medicine, NewYork-Presbyterian Hospital
| |
Collapse
|
47
|
Deng X, Lu Z, Wang X, Zhang J, Liu S, Zhang M, Meng J, Chen D, Ma S, Li H. The efficacy of function-preservation in treating paranasal sinus and nasal cavity neoplasms. Indian J Cancer 2021; 59:380-386. [PMID: 34380838 DOI: 10.4103/ijc.ijc_843_19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background Craniofacial resection (CFR) has been regarded as the gold standard for paranasal sinus and nasal cavity (PNSNC) neoplasms. The improvement of surgical procedures has been ongoing in recent years. We analyzed the clinical curative effects of the function-preservation therapy that was mainly using nasal endoscopic surgery along with appropriate radiotherapy and chemotherapy as applicable. Methods We performed a retrospective analysis of factors that influence the survival time of the 28 patients with PNSNC neoplasms who underwent nasal endoscopic surgery. All patients with tumor lesions underwent a complete resection in en bloc or piecemeal resection. Five cases did not undergo radiotherapy or chemotherapy; the remaining 23 patients had multimodality therapy. Results The median follow-up time was 41.5 (range = 14-97) months. The overall 3-year survival rate was 78.57% for T3 cancer and 50% for those with T4. T classification (P = 0.031) and multimodality therapy (P = 0.038) were independent prognostic factors for postoperative 3-year survival rate of patients with PNSNC neoplasms. Conclusion Function-preservation therapy based on the minimally invasive endoscopic resection (MIER) with appropriate adjuvant therapy not only prolonged the overall survival time but also provided an opportunity to preserve organ function at the same time, which helped to improve the patients' quality of life.
Collapse
Affiliation(s)
- Xiaoli Deng
- Key laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education, Shihezi University, Shihezi, Xin jiang, People's Republic of China
| | - Zhaoyi Lu
- Department of Otolaryngology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Xiaomin Wang
- Department of Otolaryngology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Junjie Zhang
- Department of Otolaryngology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Shixian Liu
- Department of Otolaryngology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Mingjie Zhang
- Department of Otolaryngology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Jie Meng
- Department of Otolaryngology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Deshang Chen
- Department of Otolaryngology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Shiyin Ma
- Department of Otolaryngology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Hui Li
- Department of Otolaryngology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| |
Collapse
|
48
|
Konuthula N, Perez FA, Maga AM, Abuzeid WM, Moe K, Hannaford B, Bly RA. Automated atlas-based segmentation for skull base surgical planning. Int J Comput Assist Radiol Surg 2021; 16:933-941. [PMID: 34009539 DOI: 10.1007/s11548-021-02390-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2020] [Accepted: 04/27/2021] [Indexed: 11/26/2022]
Abstract
PURPOSE Computational surgical planning tools could help develop novel skull base surgical approaches that improve safety and patient outcomes. This defines a need for automated skull base segmentation to improve the usability of surgical planning software. The objective of this work was to design and validate an algorithm for atlas-based automated segmentation of skull base structures in individual image sets for skull base surgical planning. METHODS Advanced Normalization Tools software was used to construct a synthetic CT template from 6 subjects, and skull base structures were manually segmented to create a reference atlas. Landmark registration followed by Elastix deformable registration was applied to the template to register it to each of the 30 trusted reference image sets. Dice coefficient, average Hausdorff distance, and clinical usability scoring were used to compare the atlas segmentations to those of the trusted reference image sets. RESULTS The mean for average Hausdorff distance for all structures was less than 2 mm (mean for 95th percentile Hausdorff distance was less than 5 mm). For structures greater than 2.5 mL in volume, the average Dice coefficient was 0.73 (range 0.59-0.82), and for structures less than 2.5 mL in volume the Dice coefficient was less than 0.7. The usability scoring survey was completed by three experts, and all structures met the criteria for acceptable effort except for the foramen spinosum, rotundum, and carotid artery, which required more than minor corrections. CONCLUSION Currently available open-source algorithms, such as the Elastix deformable algorithm, can be used for automated atlas-based segmentation of skull base structures with acceptable clinical accuracy and minimal corrections with the use of the proposed atlas. The first publicly available CT template and anterior skull base segmentation atlas being released (available at this link: http://hdl.handle.net/1773/46259 ) with this paper will allow for general use of automated atlas-based segmentation of the skull base.
Collapse
Affiliation(s)
- Neeraja Konuthula
- Department of Otolaryngology, Head and Neck Surgery, University of Washington, Seattle, WA, USA
| | - Francisco A Perez
- Department of Radiology, University of Washington, Seattle, WA, USA
- Division of Radiology, Seattle Children's Hospital, Seattle, WA, USA
| | - A Murat Maga
- Department of Craniofacial Medicine, University of Washington, Seattle, WA, USA
- Craniofacial Center, Seattle Children's Hospital, Seattle, WA, USA
| | - Waleed M Abuzeid
- Department of Otolaryngology, Head and Neck Surgery, University of Washington, Seattle, WA, USA
| | - Kris Moe
- Department of Otolaryngology, Head and Neck Surgery, University of Washington, Seattle, WA, USA
- Otolaryngology-Head and Neck Surgery, Harborview Medical Center, Seattle, WA, USA
| | - Blake Hannaford
- Department of Electrical and Computer Engineering, University of Washington, Seattle, WA, USA
| | - Randall A Bly
- Department of Otolaryngology, Head and Neck Surgery, University of Washington, Seattle, WA, USA.
- Division of Pediatric Otolaryngology, Head and Neck Surgery, Seattle Children's Hospital, Seattle, WA, USA.
| |
Collapse
|
49
|
Gonçalves Pacheco Junior M, de Melo Junior JO, André Acioly M, Mansilla Cabrera Rodrigues R, Lima Pessôa B, Fernandes RA, Landeiro JA. Tailored Anterior Clinoidectomy: Beyond the Intradural and Extradural Concepts. Cureus 2021; 13:e14874. [PMID: 34104602 PMCID: PMC8179565 DOI: 10.7759/cureus.14874] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Anterior clinoidectomy (AC) is a key microsurgical step for the safe and successful management of parasellar pathologies that involve the anterior clinoid process (ACP) and the optic canal. Traditionally, extra and intradural ACs are performed separately according to the surgeon's experience or preference. The objective is to present and discuss the tailored AC concept through illustrative cases. We conducted a retrospective record review of three patients who underwent AC as a surgical step for the treatment of parasellar pathologies that involve the ACP and optic canal. A review of the relevant literature on AC was performed in the PubMed, LILACS, and SciELO databases. In all three cases, the pterional craniotomy was the preferred approach for AC. Case 1, a 47-year-old female patient with type III anterior clinoidal meningioma, underwent a tailored intradural technique (optic canal unroofing) with total tumor resection and complete visual recovery. Case 2, a 63-year-old female patient with a complex type II anterior clinoidal meningioma with extensive hyperostosis of the ACP, underwent a hybrid AC technique with complete removal of the tumor and visual improvement. Case 3, a 62-year-old female, underwent a tailored intradural AC for clipping an incidental carotid-ophthalmic aneurysm. Tailored AC aims to provide adequate exposure with less risk of neurovascular injury, allowing enough space to safely treat parasellar lesions. The type, size, and location of the lesion, as well as the surgeon’s experience, should always be considered for surgical planning.
Collapse
|
50
|
Almeida JP, Gentili F. Endoscopic skull base surgery and the evolution of approaches to anterior cranial base lesions. J Neurosurg Sci 2021; 65:101-102. [PMID: 33890753 DOI: 10.23736/s0390-5616.20.05209-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Joao P Almeida
- Unit of Skull Base Surgery, Department of Neurological Surgery, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA -
| | - Fred Gentili
- Division of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada
| |
Collapse
|